record_id,policy_type,policy_op,policy_specific
Abadie_2018,8_strategies,policy_law_enforce,1_policing tactics
Abadie_2018,8_strategies,policy_harm,1_needle exchange/availability
Abouk_2019,2_legislations,policy_harm,9090_naloxone access laws
Abouk_2019,4_government policy,policy_harm,9090_naloxone access laws
Abramson_2009,1_legal,policy_harm,1_needle exchange/availability
Abramson_2009,1_legal,policy_criminal,9090_Availability of harm reduction in corrections facilities
Abramson_2009,1_legal,policy_theme,9090_International human rights treaties
Abramson_2009,4_government policy,policy_harm,1_needle exchange/availability
Abramson_2009,4_government policy,policy_criminal,9090_Availability of harm reduction in corrections facilities
Abramson_2009,4_government policy,policy_theme,9090_International human rights treaties
Accurso_2016,7_programs,policy_theme,9090_Private insurance coverage changes
Aguiar_2016,2_legislations,policy_criminal,9090_Parenting Sentencing Alternative
Ahammer_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Aitken_2002,7_programs,policy_law_enforce,1_policing tactics
Aitken_2002,7_programs,policy_law_enforce,2_police presence
Al Achkar_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Alburaih_2018,7_programs,policy_theme,9090_Standardised pain contract
Aletraris_2017,2_legislations,policy_social,2_medical insurance changes
Alexander_2014,2_legislations,policy_criminal,9090_Punitive charges for drug use while pregnant (specifically assault on fetus)
Alexandridis_2018,8_strategies,policy_harm,9090_naloxone distribution
Alexandridis_2018,8_strategies,policy_theme,9090_Education providers
Alexandridis_2018,8_strategies,policy_clinical,2_availability of OAT - provider - doctors
Alexandridis_2019,2_legislations,policy_harm,9090_naloxone policies
Alexandridis_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Alexandridis_2019,2_legislations,policy_social,9090_Support programs
Alexandridis_2019,2_legislations,policy_social,9090_2_Education programs
Alexandridis_2019,2_legislations,policy_clinical,1_availability of OAT
Alexandridis_2019,2_legislations,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Alexandridis_2019,2_legislations,policy_prescription,9090_diversion control
Alexandridis_2019,7_programs,policy_harm,9090_naloxone policies
Alexandridis_2019,7_programs,policy_legislative,1_regulation of prescription drugs
Alexandridis_2019,7_programs,policy_social,9090_Support programs
Alexandridis_2019,7_programs,policy_social,9090_2_Education programs
Alexandridis_2019,7_programs,policy_clinical,1_availability of OAT
Alexandridis_2019,7_programs,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Alexandridis_2019,7_programs,policy_prescription,9090_diversion control
Ali_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Allen_2016,4_government policy,policy_harm,1_needle exchange/availability
Allen_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Almarsdottir_2000,2_legislations,policy_legislative,9090_liberalizing community pharmacy ownership
Alpert_2017,3_regulation,policy_prescription,2_changes in drug formulation
Alsirafy_2011,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
Anders_2019,2_legislations,policy_legislative,4_legalization
Anders_2019,2_legislations,policy_social,2_medical insurance changes
Andraka-Christou_2016,2_legislations,policy_criminal,1_drug courts
Andraka-Christou_2016,2_legislations,policy_clinical,1_availability of OAT
Andraka-Christou_2016,7_programs,policy_criminal,1_drug courts
Andraka-Christou_2016,7_programs,policy_clinical,1_availability of OAT
Andraka-Christou_2016a,2_legislations,policy_clinical,1_availability of OAT
Andraka-Christou_2016a,3_regulation,policy_clinical,1_availability of OAT
Andraka-Christou_2017,2_legislations,policy_criminal,1_drug courts
Andraka-Christou_2017,2_legislations,policy_social,9090_mandated counseling
Andraka-Christou_2017,2_legislations,policy_clinical,1_availability of OAT
Andraka-Christou_2017,7_programs,policy_criminal,1_drug courts
Andraka-Christou_2017,7_programs,policy_social,9090_mandated counseling
Andraka-Christou_2017,7_programs,policy_clinical,1_availability of OAT
Andresen_2009,7_programs,policy_harm,3_SIS
Andrews_2014,3_regulation,policy_social,2_medical insurance changes
Andrews_2018,3_regulation,policy_clinical,1_availability of OAT
Andrews_2019,2_legislations,policy_social,2_medical insurance changes
Andrews_2019_2,2_legislations,policy_social,2_medical insurance changes
Angelotta_2016,1_legal,policy_criminal,9090_Court referral for substance use treatment
Angelotta_2016,1_legal,policy_legislative,9090_Prenatal child abuse laws for women who use illicit drugs during pregnancy
Angelotta_2016,2_legislations,policy_criminal,9090_Court referral for substance use treatment
Angelotta_2016,2_legislations,policy_legislative,9090_Prenatal child abuse laws for women who use illicit drugs during pregnancy
Angelotta_2017,1_legal,policy_criminal,2_punitive charges
Angelotta_2017,1_legal,policy_criminal,9090_Substance use while pregnant
Anglin_2013,2_legislations,policy_criminal,1_drug courts
Anglin_2013_2,2_legislations,policy_criminal,1_drug courts
Arredondo_2018,4_government policy,policy_law_enforce,1_policing tactics
Arredondo_2018,4_government policy,policy_legislative,3_decriminalization
Asher_2013,7_programs,policy_clinical,1_availability of OAT
Atkins_2018,2_legislations,policy_legislative,5_first responders
Aubrun_2007,3_regulation,policy_prescription,3_withdraw drug
Auerhahn_2004,2_legislations,policy_criminal,1_drug courts
Ayres_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Azrin_2007,2_legislations,policy_social,2_medical insurance changes
Azzone_2011,2_legislations,policy_social,2_medical insurance changes
Bachhuber_2014,2_legislations,policy_legislative,4_legalization
Bachhuber_2018,2_legislations,policy_social,2_medical insurance changes
Bachhuber_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Baicker_2017,2_legislations,policy_social,2_medical insurance changes
Bammer_2000,7_programs,policy_clinical,1_availability of OAT
Bao_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
Bao_2018,2_legislations,policy_theme,9090_Data sharing program
Bao_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Bao_2018,3_regulation,policy_theme,9090_Data sharing program
Bao_2018,3_regulation,policy_legislative,1_regulation of prescription drugs
Bao_2018,4_government policy,policy_theme,9090_Data sharing program
Bao_2018,4_government policy,policy_legislative,1_regulation of prescription drugs
Bao_2018,5_guidelines,policy_theme,9090_Data sharing program
Bao_2018,5_guidelines,policy_legislative,1_regulation of prescription drugs
Bao_2018,7_programs,policy_theme,9090_Data sharing program
Bao_2018,7_programs,policy_legislative,1_regulation of prescription drugs
Barber_2017,5_guidelines,policy_clinical,4_opioid prescribing standards
Barnes_2013,2_legislations,policy_legislative,1_regulation of prescription drugs
Barnett_2018,6_standards,policy_social,2_medical insurance changes
Bartelson_2017,8_strategies,policy_clinical,9090_ER/LA Opioid Analgesic Risk Evaluation and Mitigation Strategy
Barthwell_2016,3_regulation,policy_clinical,2_availability of OAT - provider - doctors
Beaudoin_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
Beaudoin_2016,2_legislations,policy_legislative,9090_pain clinic laws
Beaudoin_2016,2_legislations,policy_clinical,2_availability of OAT - provider - doctors
Beaudoin_2016,2_legislations,policy_clinical,4_opioid prescribing standards
Beaudoin_2016,3_regulation,policy_legislative,1_regulation of prescription drugs
Beaudoin_2016,3_regulation,policy_legislative,9090_pain clinic laws
Beaudoin_2016,3_regulation,policy_clinical,2_availability of OAT - provider - doctors
Beaudoin_2016,3_regulation,policy_clinical,4_opioid prescribing standards
Beaudoin_2016,5_guidelines,policy_legislative,1_regulation of prescription drugs
Beaudoin_2016,5_guidelines,policy_legislative,9090_pain clinic laws
Beaudoin_2016,5_guidelines,policy_clinical,2_availability of OAT - provider - doctors
Beaudoin_2016,5_guidelines,policy_clinical,4_opioid prescribing standards
Beaudoin_2016,7_programs,policy_legislative,1_regulation of prescription drugs
Beaudoin_2016,7_programs,policy_legislative,9090_pain clinic laws
Beaudoin_2016,7_programs,policy_clinical,2_availability of OAT - provider - doctors
Beaudoin_2016,7_programs,policy_clinical,4_opioid prescribing standards
Becquemont_2014,3_regulation,policy_prescription,3_withdraw drug
Beheshti_2018,3_regulation,policy_prescription,2_changes in drug formulation
Beletsky_2008,2_legislations,policy_harm,3_SIS
Ben-Joseph_2014,3_regulation,policy_social,2_medical insurance changes
Bernhardt_2017,3_regulation,policy_prescription,1_drug rescheduling
Bernstein_2013,2_legislations,policy_harm,1_needle exchange/availability
Bernstein_2013,2_legislations,policy_legislative,9090_Municipal Zoning
Best_2010,7_programs,policy_law_enforce,2_police presence
Best_2010,7_programs,policy_clinical,7_compulsory treatment
Biddulph_2011,2_legislations,policy_law_enforce,1_policing tactics
Biddulph_2011,2_legislations,policy_law_enforce,2_police presence
Biddulph_2011,2_legislations,policy_law_enforce,9090_monitoring and surveillance
Biddulph_2011,2_legislations,policy_criminal,2_punitive charges
Biddulph_2011,2_legislations,policy_criminal,9090_involuntary treatment
Biddulph_2011,2_legislations,policy_theme,"9090_mandatory registration of drug users, who can then be tested for drugs at any time"
Biddulph_2011,2_legislations,policy_legislative,2_illicit drug policies
Biddulph_2011,2_legislations,policy_clinical,7_compulsory treatment
Biddulph_2011,2_legislations,policy_clinical,9090_Coersive police treatment centres or labour camps
Biddulph_2011,7_programs,policy_law_enforce,1_policing tactics
Biddulph_2011,7_programs,policy_law_enforce,2_police presence
Biddulph_2011,7_programs,policy_law_enforce,9090_monitoring and surveillance
Biddulph_2011,7_programs,policy_criminal,2_punitive charges
Biddulph_2011,7_programs,policy_criminal,9090_involuntary treatment
Biddulph_2011,7_programs,policy_theme,"9090_mandatory registration of drug users, who can then be tested for drugs at any time"
Biddulph_2011,7_programs,policy_legislative,2_illicit drug policies
Biddulph_2011,7_programs,policy_clinical,7_compulsory treatment
Biddulph_2011,7_programs,policy_clinical,9090_Coersive police treatment centres or labour camps
Bird_2015,7_programs,policy_clinical,1_availability of OAT
Bird_2016,7_programs,policy_harm,9090_national naloxone programme
Birk_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Black_2019,8_strategies,policy_clinical,9090_ER/LA Risk Evaluation and Mitigation Strategy
Blanchard_2016,5_guidelines,policy_clinical,1_availability of OAT
Blanchard_2016,5_guidelines,policy_clinical,4_opioid prescribing standards
Blanchard_2016,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Blanchard_2016,8_strategies,policy_clinical,1_availability of OAT
Blanchard_2016,8_strategies,policy_clinical,4_opioid prescribing standards
Blanchard_2016,8_strategies,policy_clinical,5_opioid prescribing standards - provider - doctor
Blanchard_2018,2_legislations,policy_harm,9090_naloxone program
Blanchard_2018,2_legislations,policy_legislative,5_first responders
Blanchard_2018,2_legislations,policy_clinical,1_availability of OAT
Blanchard_2018,7_programs,policy_harm,9090_naloxone program
Blanchard_2018,7_programs,policy_legislative,5_first responders
Blanchard_2018,7_programs,policy_clinical,1_availability of OAT
Bleyer_2019,2_legislations,policy_legislative,4_legalization
Bluthenthal_2018,2_legislations,policy_harm,1_needle exchange/availability
Bobashev_2018,2_legislations,policy_harm,9090_naloxone
Bobashev_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Bobashev_2018,2_legislations,policy_clinical,1_availability of OAT
Bobashev_2018,2_legislations,policy_prescription,2_changes in drug formulation
Bobashev_2018,3_regulation,policy_harm,9090_naloxone
Bobashev_2018,3_regulation,policy_legislative,1_regulation of prescription drugs
Bobashev_2018,3_regulation,policy_clinical,1_availability of OAT
Bobashev_2018,3_regulation,policy_prescription,2_changes in drug formulation
Bobashev_2018,7_programs,policy_harm,9090_naloxone
Bobashev_2018,7_programs,policy_legislative,1_regulation of prescription drugs
Bobashev_2018,7_programs,policy_clinical,1_availability of OAT
Bobashev_2018,7_programs,policy_prescription,2_changes in drug formulation
Boehnke_2016,7_programs,policy_theme,9090_medical cannabis
Bohnert_2011,7_programs,policy_law_enforce,1_policing tactics
Bohnert_2018,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Borquez_2018,2_legislations,policy_legislative,3_decriminalization
Boyer_2008,3_regulation,policy_theme,9090_Regulation of online pharmacies
Bradbury_2014,4_government policy,policy_harm,"9090_pre-release (from prison) counselling on OD risks and prevention, and training in 1st aid and OD management"
Bradbury_2014,4_government policy,policy_harm,9090_2_Naloxone - THN
Bradbury_2014,4_government policy,policy_criminal,9090_This paper wasn't specifically talking about criminal justice policies; rather the whole paper is about the impact of OD and drug treatment programs for the population that is being released from prison.
Bradbury_2014,4_government policy,policy_clinical,1_availability of OAT
Bradbury_2014,7_programs,policy_harm,"9090_pre-release (from prison) counselling on OD risks and prevention, and training in 1st aid and OD management"
Bradbury_2014,7_programs,policy_harm,9090_2_Naloxone - THN
Bradbury_2014,7_programs,policy_criminal,9090_This paper wasn't specifically talking about criminal justice policies; rather the whole paper is about the impact of OD and drug treatment programs for the population that is being released from prison.
Bradbury_2014,7_programs,policy_clinical,1_availability of OAT
Bradbury_2014,8_strategies,policy_harm,"9090_pre-release (from prison) counselling on OD risks and prevention, and training in 1st aid and OD management"
Bradbury_2014,8_strategies,policy_harm,9090_2_Naloxone - THN
Bradbury_2014,8_strategies,policy_criminal,9090_This paper wasn't specifically talking about criminal justice policies; rather the whole paper is about the impact of OD and drug treatment programs for the population that is being released from prison.
Bradbury_2014,8_strategies,policy_clinical,1_availability of OAT
Bradbury_2014a,4_government policy,policy_harm,9090_Naloxone - THN
Bradbury_2014a,4_government policy,policy_criminal,9090_This paper wasn't specifically talking about criminal justice policies; rather the whole paper is about the impact of OD and drug treatment programs for the population that is being released from prison.
Bradbury_2014a,4_government policy,policy_clinical,1_availability of OAT
Bradbury_2014a,7_programs,policy_harm,9090_Naloxone - THN
Bradbury_2014a,7_programs,policy_criminal,9090_This paper wasn't specifically talking about criminal justice policies; rather the whole paper is about the impact of OD and drug treatment programs for the population that is being released from prison.
Bradbury_2014a,7_programs,policy_clinical,1_availability of OAT
Bradbury_2014a,8_strategies,policy_harm,9090_Naloxone - THN
Bradbury_2014a,8_strategies,policy_criminal,9090_This paper wasn't specifically talking about criminal justice policies; rather the whole paper is about the impact of OD and drug treatment programs for the population that is being released from prison.
Bradbury_2014a,8_strategies,policy_clinical,1_availability of OAT
Bradford_2016,2_legislations,policy_legislative,4_legalization
Bradford_2018,2_legislations,policy_legislative,4_legalization
Brady_2014,2_legislations,policy_legislative,1_regulation of prescription drugs
Brands_2003,7_programs,policy_clinical,1_availability of OAT
Branham_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Bravo_2007,7_programs,policy_harm,1_needle exchange/availability
Brighthaupt_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Brown_2010,1_legal,policy_criminal,1_drug courts
Brown_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Brownsberger_2004,2_legislations,policy_criminal,2_punitive charges
Brownsberger_2004,2_legislations,policy_legislative,9090_Increased penalties for dealing in school zones
Bruce_2009,4_government policy,policy_prescription,2_changes in drug formulation
Bruce_2009,5_guidelines,policy_prescription,2_changes in drug formulation
Buchmueller_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Buer_2014,4_government policy,policy_prescription,2_changes in drug formulation
Buhl_2004,2_legislations,policy_legislative,9090_mandated responsibility for care of Problem Drug Users to govt (away from GPs and private clinics)
Buhl_2004,2_legislations,policy_clinical,9090_mandated responsibility for medical treatment of PDU from GP or private clinic to county/government clinic.
Bunting_2019,2_legislations,policy_harm,1_needle exchange/availability
Bunting_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Bunting_2019,2_legislations,policy_legislative,5_first responders
Bunting_2019,2_legislations,policy_prescription,2_changes in drug formulation
Bunting_2019,3_regulation,policy_harm,1_needle exchange/availability
Bunting_2019,3_regulation,policy_legislative,1_regulation of prescription drugs
Bunting_2019,3_regulation,policy_legislative,5_first responders
Bunting_2019,3_regulation,policy_prescription,2_changes in drug formulation
Burger_2017,2_legislations,policy_legislative,2_illicit drug policies
Burns_2016,4_government policy,policy_social,2_medical insurance changes
Burns_2016,4_government policy,policy_clinical,4_opioid prescribing standards
Burns_2016,4_government policy,policy_prescription,1_drug rescheduling
Burns_2016,4_government policy,policy_prescription,2_changes in drug formulation
Burns_2016,4_government policy,policy_prescription,9090_Administrative barriers
Burns_2016,5_guidelines,policy_social,2_medical insurance changes
Burns_2016,5_guidelines,policy_clinical,4_opioid prescribing standards
Burns_2016,5_guidelines,policy_prescription,1_drug rescheduling
Burns_2016,5_guidelines,policy_prescription,2_changes in drug formulation
Burns_2016,5_guidelines,policy_prescription,9090_Administrative barriers
Burns_2016,7_programs,policy_social,2_medical insurance changes
Burns_2016,7_programs,policy_clinical,4_opioid prescribing standards
Burns_2016,7_programs,policy_prescription,1_drug rescheduling
Burns_2016,7_programs,policy_prescription,2_changes in drug formulation
Burns_2016,7_programs,policy_prescription,9090_Administrative barriers
Burns_2016,8_strategies,policy_social,2_medical insurance changes
Burns_2016,8_strategies,policy_clinical,4_opioid prescribing standards
Burns_2016,8_strategies,policy_prescription,1_drug rescheduling
Burns_2016,8_strategies,policy_prescription,2_changes in drug formulation
Burns_2016,8_strategies,policy_prescription,9090_Administrative barriers
Busch_2014,2_legislations,policy_social,2_medical insurance changes
Butler_2013,3_regulation,policy_prescription,2_changes in drug formulation
Cady_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Cahill_2003,2_legislations,policy_legislative,"9090_Client monitoring system (ie, patient treatment list for all patients prescribed methadone)"
Cahill_2003,2_legislations,policy_clinical,2_availability of OAT - provider - doctors
Cahill_2003,2_legislations,policy_clinical,4_opioid prescribing standards
Cahill_2003,3_regulation,policy_legislative,"9090_Client monitoring system (ie, patient treatment list for all patients prescribed methadone)"
Cahill_2003,3_regulation,policy_clinical,2_availability of OAT - provider - doctors
Cahill_2003,3_regulation,policy_clinical,4_opioid prescribing standards
Cairns_2016,3_regulation,policy_prescription,1_drug rescheduling
Calsyn_2003,7_programs,policy_clinical,7_compulsory treatment
Capoccia_2012,2_legislations,policy_social,2_medical insurance changes
Cassidy_2014,3_regulation,policy_prescription,2_changes in drug formulation
Cassidy_2017,3_regulation,policy_prescription,2_changes in drug formulation
Castillo-Carniglia_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Casturi_2013,2_legislations,policy_legislative,1_regulation of prescription drugs
CDC_nd,2_legislations,policy_legislative,1_regulation of prescription drugs
CDC_nd_2,2_legislations,policy_legislative,1_regulation of prescription drugs
CDC_nd_3,2_legislations,policy_legislative,1_regulation of prescription drugs
CDC_nd_4,2_legislations,policy_legislative,1_regulation of prescription drugs
CDC_nd_5,2_legislations,policy_legislative,1_regulation of prescription drugs
CDC_nd_6,3_regulation,policy_legislative,9090_pain clinic laws
CDC_nd_7,2_legislations,policy_legislative,1_regulation of prescription drugs
Cerda_2018,2_legislations,policy_legislative,4_legalization
Chacko_2017,7_programs,policy_clinical,5_opioid prescribing standards - provider - doctor
Chambers_2015,3_regulation,policy_prescription,1_drug rescheduling
Chan_2019,2_legislations,policy_legislative,4_legalization
Chang_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
Chang_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Chang_2018_2,3_regulation,policy_prescription,2_changes in drug formulation
Chen_2016,4_government policy,policy_harm,1_needle exchange/availability
Chen_2016,4_government policy,policy_clinical,1_availability of OAT
Chen_2018,3_regulation,policy_prescription,2_changes in drug formulation
Chen_2019,5_guidelines,policy_clinical,4_opioid prescribing standards
Chen_2019,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Chen_2019,5_guidelines,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Cherny_2010,2_legislations,policy_legislative,1_regulation of prescription drugs
Cheurprakobkit_2000,4_government policy,policy_legislative,9090_Drug suppression and prevention policies
Cheurprakobkit_2000,4_government policy,policy_clinical,7_compulsory treatment
Chihuri_2019,2_legislations,policy_legislative,4_legalization
Chilcoat_2016,3_regulation,policy_prescription,2_changes in drug formulation
Chiu_2018,7_programs,policy_prescription,9090_Lowering default pill counts in EMR system
Christopher_2015,2_legislations,policy_legislative,9090_substance  related civil commitment laws
Chu_2015,2_legislations,policy_legislative,4_legalization
Chumpitazi_2017,3_regulation,policy_prescription,1_drug rescheduling
Chun_2007,2_legislations,policy_criminal,1_drug courts
Cicero_2015,3_regulation,policy_prescription,2_changes in drug formulation
Cicero_2019,3_regulation,policy_prescription,2_changes in drug formulation
Clark_2014,4_government policy,policy_social,2_medical insurance changes
Clark_2014,4_government policy,policy_clinical,1_availability of OAT
Cleary_2013,3_regulation,policy_legislative,1_regulation of prescription drugs
Cleary_2013_2,2_legislations,policy_prescription,9090_A variety related to restrictions on prescribing of opioids
Cleary_2013_2,3_regulation,policy_prescription,9090_A variety related to restrictions on prescribing of opioids
Cleary_2013_3,2_legislations,policy_legislative,1_regulation of prescription drugs
Cleary_2013_3,3_regulation,policy_legislative,1_regulation of prescription drugs
Cleary_2013_4,2_legislations,policy_legislative,1_regulation of prescription drugs
Cleary_2013_4,3_regulation,policy_legislative,1_regulation of prescription drugs
Cleary_2013_5,2_legislations,policy_legislative,1_regulation of prescription drugs
Cleary_2013_5,3_regulation,policy_legislative,1_regulation of prescription drugs
Cochella_2011,7_programs,policy_clinical,5_opioid prescribing standards - provider - doctor
Cochran_2017,2_legislations,policy_social,2_medical insurance changes
Cooper_2005,8_strategies,policy_law_enforce,1_policing tactics
Cooper_2005_2,8_strategies,policy_law_enforce,1_policing tactics
Cooper_2005_2,8_strategies,policy_law_enforce,2_police presence
Coplan_2013,3_regulation,policy_prescription,2_changes in drug formulation
Coplan_2016,3_regulation,policy_prescription,2_changes in drug formulation
Corcoran_2010,3_regulation,policy_prescription,3_withdraw drug
Corsaro_2010,8_strategies,policy_law_enforce,1_policing tactics
Corsaro_2012,8_strategies,policy_law_enforce,1_policing tactics
Corsaro_2013,8_strategies,policy_law_enforce,1_policing tactics
Costa Storti_2009,8_strategies,policy_law_enforce,9090_supply containment policies
Cotti_2014,7_programs,policy_criminal,9090_Diversion
Courtwright_2004,2_legislations,policy_legislative,2_illicit drug policies
Courtwright_2004,8_strategies,policy_legislative,2_illicit drug policies
Cowell_2004,3_regulation,policy_criminal,9090_diversion
Crabtree_2019,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Csete_2013,4_government policy,policy_criminal,1_drug courts
Csete_2013,7_programs,policy_criminal,1_drug courts
Cunningham_2008,2_legislations,policy_legislative,1_regulation of prescription drugs
Danovich_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Dart_2018,3_regulation,policy_prescription,2_changes in drug formulation
Dave_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Davis_2006,3_regulation,policy_law_enforce,2_police presence
Davis_2014_1,2_legislations,policy_legislative,1_regulation of prescription drugs
Davis_2014_1,3_regulation,policy_legislative,1_regulation of prescription drugs
Davis_2014_2,2_legislations,policy_legislative,5_first responders
Davis_2014_2,3_regulation,policy_legislative,5_first responders
Davis_2014_2,4_government policy,policy_legislative,5_first responders
Davis_2015,2_legislations,policy_prescription,9090_access to naloxone
Davis_2015,3_regulation,policy_prescription,9090_access to naloxone
Davis_2015,4_government policy,policy_prescription,9090_access to naloxone
Davis_2015_2,7_programs,policy_law_enforce,9090_naloxone administration by police
Davis_2016,2_legislations,policy_theme,9090_CME/physician education laws
Davis_2016,3_regulation,policy_theme,9090_CME/physician education laws
Davis_2017,2_legislations,policy_harm,9090_prescription of naloxone
Davis_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Davis_2017,2_legislations,policy_prescription,9090_prescription of naloxone
Davis_2017,3_regulation,policy_harm,9090_prescription of naloxone
Davis_2017,3_regulation,policy_legislative,1_regulation of prescription drugs
Davis_2017,3_regulation,policy_prescription,9090_prescription of naloxone
Davis_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Davis_2019,2_legislations,policy_clinical,4_opioid prescribing standards
Davis_2019,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
Davis_2019,2_legislations,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Davis_2019,2_legislations,policy_prescription,1_drug rescheduling
Davis_2019,3_regulation,policy_legislative,1_regulation of prescription drugs
Davis_2019,3_regulation,policy_clinical,4_opioid prescribing standards
Davis_2019,3_regulation,policy_clinical,5_opioid prescribing standards - provider - doctor
Davis_2019,3_regulation,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Davis_2019,3_regulation,policy_prescription,1_drug rescheduling
Davis_2019,4_government policy,policy_legislative,1_regulation of prescription drugs
Davis_2019,4_government policy,policy_clinical,4_opioid prescribing standards
Davis_2019,4_government policy,policy_clinical,5_opioid prescribing standards - provider - doctor
Davis_2019,4_government policy,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Davis_2019,4_government policy,policy_prescription,1_drug rescheduling
Davis_2019,5_guidelines,policy_legislative,1_regulation of prescription drugs
Davis_2019,5_guidelines,policy_clinical,4_opioid prescribing standards
Davis_2019,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Davis_2019,5_guidelines,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Davis_2019,5_guidelines,policy_prescription,1_drug rescheduling
Davis_2019,6_standards,policy_legislative,1_regulation of prescription drugs
Davis_2019,6_standards,policy_clinical,4_opioid prescribing standards
Davis_2019,6_standards,policy_clinical,5_opioid prescribing standards - provider - doctor
Davis_2019,6_standards,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Davis_2019,6_standards,policy_prescription,1_drug rescheduling
Davis_2019,7_programs,policy_legislative,1_regulation of prescription drugs
Davis_2019,7_programs,policy_clinical,4_opioid prescribing standards
Davis_2019,7_programs,policy_clinical,5_opioid prescribing standards - provider - doctor
Davis_2019,7_programs,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Davis_2019,7_programs,policy_prescription,1_drug rescheduling
Davis_2019_2,2_legislations,policy_legislative,1_regulation of prescription drugs
Davis_2019_2,3_regulation,policy_legislative,1_regulation of prescription drugs
De Lima_2001,2_legislations,policy_legislative,1_regulation of prescription drugs
De Lima_2001,3_regulation,policy_legislative,1_regulation of prescription drugs
De Wree_2009,7_programs,policy_criminal,1_drug courts
Deacon_2016,3_regulation,policy_prescription,1_drug rescheduling
DeBeck_2017,2_legislations,policy_law_enforce,1_policing tactics
DeBeck_2017,2_legislations,policy_law_enforce,2_police presence
DeBeck_2017,2_legislations,policy_criminal,2_punitive charges
DeBeck_2017,2_legislations,policy_legislative,2_illicit drug policies
DeBeck_2017,3_regulation,policy_law_enforce,1_policing tactics
DeBeck_2017,3_regulation,policy_law_enforce,2_police presence
DeBeck_2017,3_regulation,policy_criminal,2_punitive charges
DeBeck_2017,3_regulation,policy_legislative,2_illicit drug policies
DeBeck_2017,8_strategies,policy_law_enforce,1_policing tactics
DeBeck_2017,8_strategies,policy_law_enforce,2_police presence
DeBeck_2017,8_strategies,policy_criminal,2_punitive charges
DeBeck_2017,8_strategies,policy_legislative,2_illicit drug policies
DeFulio_2013,1_legal,policy_criminal,1_drug courts
Degenhardt_2015,3_regulation,policy_prescription,2_changes in drug formulation
Deiana_2019,2_legislations,policy_theme,9090_doctor shopping laws
Deiana_2019,2_legislations,policy_legislative,4_legalization
Deiana_2019,2_legislations,policy_legislative,9090_pain clinic laws
Deiana_2019,3_regulation,policy_theme,9090_doctor shopping laws
Deiana_2019,3_regulation,policy_legislative,4_legalization
Deiana_2019,3_regulation,policy_legislative,9090_pain clinic laws
Delcher_2015,2_legislations,policy_legislative,1_regulation of prescription drugs
Delcher_2017,3_regulation,policy_prescription,3_withdraw drug
DeSimone_2005,7_programs,policy_harm,1_needle exchange/availability
Dhalla_2009,8_strategies,policy_prescription,2_changes in drug formulation
Dhanda_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Dhanda_2018,2_legislations,policy_legislative,9090_pain clinic laws
Dick_2015,3_regulation,policy_clinical,2_availability of OAT - provider - doctors
Dillender_2018,2_legislations,policy_social,2_medical insurance changes
Dineen_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
Dineen_2016,3_regulation,policy_legislative,1_regulation of prescription drugs
Divino_2017,8_strategies,policy_clinical,9090_ER/LA Risk Evaluation and Mitigation Strategy
Dolan_2015,2_legislations,policy_clinical,7_compulsory treatment
Doleac_2019,4_government policy,policy_harm,9090_naloxone access laws
Dorf_2000,7_programs,policy_criminal,1_drug courts
Dormuth_2012,2_legislations,policy_legislative,1_regulation of prescription drugs
Dow_2019,2_legislations,policy_theme,9090_minimum wage increases
Dowell_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
Dowell_2016,2_legislations,policy_legislative,9090_pain clinic laws
Dowell_2016,3_regulation,policy_legislative,1_regulation of prescription drugs
Dowell_2016,3_regulation,policy_legislative,9090_pain clinic laws
Dray_2008,8_strategies,policy_law_enforce,1_policing tactics
Driscoll_2017,1_legal,policy_criminal,1_drug courts
Driscoll_2017,7_programs,policy_criminal,1_drug courts
Drucker_2013,2_legislations,policy_criminal,9090_sentencing and incarceration
Drucker_2013,2_legislations,policy_legislative,3_decriminalization
Drucker_2013,2_legislations,policy_social,1_welfare expansion/reform
Drucker_2013,2_legislations,policy_social,9090_Services avaliable on release from corrections
Drucker_2013,3_regulation,policy_criminal,9090_sentencing and incarceration
Drucker_2013,3_regulation,policy_legislative,3_decriminalization
Drucker_2013,3_regulation,policy_social,1_welfare expansion/reform
Drucker_2013,3_regulation,policy_social,9090_Services avaliable on release from corrections
Drucker_2013,4_government policy,policy_criminal,9090_sentencing and incarceration
Drucker_2013,4_government policy,policy_legislative,3_decriminalization
Drucker_2013,4_government policy,policy_social,1_welfare expansion/reform
Drucker_2013,4_government policy,policy_social,9090_Services avaliable on release from corrections
Drucker_2013,8_strategies,policy_criminal,9090_sentencing and incarceration
Drucker_2013,8_strategies,policy_legislative,3_decriminalization
Drucker_2013,8_strategies,policy_social,1_welfare expansion/reform
Drucker_2013,8_strategies,policy_social,9090_Services avaliable on release from corrections
Drug Policy Alliance_2017,2_legislations,policy_criminal,2_punitive charges
Dublin_2019,7_programs,policy_theme,9090_Opioid risk reduction initiative
Ducharme_2008,3_regulation,policy_social,2_medical insurance changes
Duppong_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Durning_2005,1_legal,policy_theme,9090_tort law as an enforcement mechanism for irresponsible marketing/distribution
Durning_2005,1_legal,policy_clinical,2_availability of OAT - provider - doctors
Durning_2005,1_legal,policy_clinical,3_availability of OAT - provider - pharmacists
Durning_2005,1_legal,policy_clinical,4_opioid prescribing standards
Durning_2005,1_legal,policy_clinical,5_opioid prescribing standards - provider - doctor
Durning_2005,1_legal,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Durning_2005,1_legal,policy_prescription,9090_prescribing practices and enforcement
Durning_2005,2_legislations,policy_theme,9090_tort law as an enforcement mechanism for irresponsible marketing/distribution
Durning_2005,2_legislations,policy_clinical,2_availability of OAT - provider - doctors
Durning_2005,2_legislations,policy_clinical,3_availability of OAT - provider - pharmacists
Durning_2005,2_legislations,policy_clinical,4_opioid prescribing standards
Durning_2005,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
Durning_2005,2_legislations,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Durning_2005,2_legislations,policy_prescription,9090_prescribing practices and enforcement
Durning_2005,3_regulation,policy_theme,9090_tort law as an enforcement mechanism for irresponsible marketing/distribution
Durning_2005,3_regulation,policy_clinical,2_availability of OAT - provider - doctors
Durning_2005,3_regulation,policy_clinical,3_availability of OAT - provider - pharmacists
Durning_2005,3_regulation,policy_clinical,4_opioid prescribing standards
Durning_2005,3_regulation,policy_clinical,5_opioid prescribing standards - provider - doctor
Durning_2005,3_regulation,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Durning_2005,3_regulation,policy_prescription,9090_prescribing practices and enforcement
Durning_2005,4_government policy,policy_theme,9090_tort law as an enforcement mechanism for irresponsible marketing/distribution
Durning_2005,4_government policy,policy_clinical,2_availability of OAT - provider - doctors
Durning_2005,4_government policy,policy_clinical,3_availability of OAT - provider - pharmacists
Durning_2005,4_government policy,policy_clinical,4_opioid prescribing standards
Durning_2005,4_government policy,policy_clinical,5_opioid prescribing standards - provider - doctor
Durning_2005,4_government policy,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Durning_2005,4_government policy,policy_prescription,9090_prescribing practices and enforcement
Durning_2005,5_guidelines,policy_theme,9090_tort law as an enforcement mechanism for irresponsible marketing/distribution
Durning_2005,5_guidelines,policy_clinical,2_availability of OAT - provider - doctors
Durning_2005,5_guidelines,policy_clinical,3_availability of OAT - provider - pharmacists
Durning_2005,5_guidelines,policy_clinical,4_opioid prescribing standards
Durning_2005,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Durning_2005,5_guidelines,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Durning_2005,5_guidelines,policy_prescription,9090_prescribing practices and enforcement
Durning_2005,6_standards,policy_theme,9090_tort law as an enforcement mechanism for irresponsible marketing/distribution
Durning_2005,6_standards,policy_clinical,2_availability of OAT - provider - doctors
Durning_2005,6_standards,policy_clinical,3_availability of OAT - provider - pharmacists
Durning_2005,6_standards,policy_clinical,4_opioid prescribing standards
Durning_2005,6_standards,policy_clinical,5_opioid prescribing standards - provider - doctor
Durning_2005,6_standards,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Durning_2005,6_standards,policy_prescription,9090_prescribing practices and enforcement
Durning_2005,8_strategies,policy_theme,9090_tort law as an enforcement mechanism for irresponsible marketing/distribution
Durning_2005,8_strategies,policy_clinical,2_availability of OAT - provider - doctors
Durning_2005,8_strategies,policy_clinical,3_availability of OAT - provider - pharmacists
Durning_2005,8_strategies,policy_clinical,4_opioid prescribing standards
Durning_2005,8_strategies,policy_clinical,5_opioid prescribing standards - provider - doctor
Durning_2005,8_strategies,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Durning_2005,8_strategies,policy_prescription,9090_prescribing practices and enforcement
Dutko_2010,2_legislations,policy_legislative,1_regulation of prescription drugs
Dzotsenidze_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
ECDC_2013,4_government policy,policy_clinical,1_availability of OAT
ECDC_2015,4_government policy,policy_clinical,1_availability of OAT
Edwards_2000,4_government policy,policy_criminal,9090_coercive treatment in corrections
Edwards_2000,4_government policy,policy_clinical,7_compulsory treatment
Edwards_2000,7_programs,policy_criminal,9090_coercive treatment in corrections
Edwards_2000,7_programs,policy_clinical,7_compulsory treatment
Egan_2004,2_legislations,policy_harm,9090_allows citizens to administer naloxone
Egan_2004,2_legislations,policy_legislative,5_first responders
EMCDDA_2002,2_legislations,policy_law_enforce,1_policing tactics
EMCDDA_2002,2_legislations,policy_criminal,1_drug courts
EMCDDA_2002,2_legislations,policy_criminal,2_punitive charges
EMCDDA_2002,2_legislations,policy_legislative,2_illicit drug policies
EMCDDA_2002,2_legislations,policy_clinical,1_availability of OAT
EMCDDA_2002,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
EMCDDA_2002,8_strategies,policy_law_enforce,1_policing tactics
EMCDDA_2002,8_strategies,policy_criminal,1_drug courts
EMCDDA_2002,8_strategies,policy_criminal,2_punitive charges
EMCDDA_2002,8_strategies,policy_legislative,2_illicit drug policies
EMCDDA_2002,8_strategies,policy_clinical,1_availability of OAT
EMCDDA_2002,8_strategies,policy_clinical,5_opioid prescribing standards - provider - doctor
EMCDDA_2003,2_legislations,policy_law_enforce,1_policing tactics
EMCDDA_2003,2_legislations,policy_harm,1_needle exchange/availability
EMCDDA_2003,2_legislations,policy_harm,3_SIS
EMCDDA_2003,2_legislations,policy_harm,9090_heroin prescription
EMCDDA_2003,2_legislations,policy_harm,9090_2_safer use education
EMCDDA_2003,2_legislations,policy_harm,"9090_3_low--threshold education, first aid courses"
EMCDDA_2003,2_legislations,policy_criminal,2_punitive charges
EMCDDA_2003,2_legislations,policy_legislative,9090_Measures to reduce public order/nuisance offences
EMCDDA_2003,2_legislations,policy_clinical,1_availability of OAT
EMCDDA_2003,2_legislations,policy_clinical,4_opioid prescribing standards
EMCDDA_2003,4_government policy,policy_law_enforce,1_policing tactics
EMCDDA_2003,4_government policy,policy_harm,1_needle exchange/availability
EMCDDA_2003,4_government policy,policy_harm,3_SIS
EMCDDA_2003,4_government policy,policy_harm,9090_heroin prescription
EMCDDA_2003,4_government policy,policy_harm,9090_2_safer use education
EMCDDA_2003,4_government policy,policy_harm,"9090_3_low--threshold education, first aid courses"
EMCDDA_2003,4_government policy,policy_criminal,2_punitive charges
EMCDDA_2003,4_government policy,policy_legislative,9090_Measures to reduce public order/nuisance offences
EMCDDA_2003,4_government policy,policy_clinical,1_availability of OAT
EMCDDA_2003,4_government policy,policy_clinical,4_opioid prescribing standards
EMCDDA_2003,8_strategies,policy_law_enforce,1_policing tactics
EMCDDA_2003,8_strategies,policy_harm,1_needle exchange/availability
EMCDDA_2003,8_strategies,policy_harm,3_SIS
EMCDDA_2003,8_strategies,policy_harm,9090_heroin prescription
EMCDDA_2003,8_strategies,policy_harm,9090_2_safer use education
EMCDDA_2003,8_strategies,policy_harm,"9090_3_low--threshold education, first aid courses"
EMCDDA_2003,8_strategies,policy_criminal,2_punitive charges
EMCDDA_2003,8_strategies,policy_legislative,9090_Measures to reduce public order/nuisance offences
EMCDDA_2003,8_strategies,policy_clinical,1_availability of OAT
EMCDDA_2003,8_strategies,policy_clinical,4_opioid prescribing standards
EMCDDA_2005,2_legislations,policy_legislative,2_illicit drug policies
EMCDDA_2005,2_legislations,policy_clinical,1_availability of OAT
EMCDDA_2005,2_legislations,policy_clinical,7_compulsory treatment
EMCDDA_2015,2_legislations,policy_criminal,1_drug courts
EMCDDA_2015,2_legislations,policy_legislative,3_decriminalization
EMCDDA_2015,2_legislations,policy_legislative,9090_Various alternatives to punishment
EMCDDA_2015,2_legislations,policy_clinical,7_compulsory treatment
EMCDDA_2015_2,8_strategies,policy_harm,1_needle exchange/availability
EMCDDA_2015_2,8_strategies,policy_harm,3_SIS
EMCDDA_2015_2,8_strategies,policy_harm,9090_low-threshold service delivery
EMCDDA_2015_2,8_strategies,policy_harm,9090_2_Naloxone
Erfanian_2019,2_legislations,policy_harm,9090_naloxone access laws
Erfanian_2019,4_government policy,policy_harm,9090_naloxone access laws
Erickson_2005,4_government policy,policy_social,1_welfare expansion/reform
Ernst_2014,1_legal,policy_criminal,2_punitive charges
Ernst_2014,2_legislations,policy_criminal,2_punitive charges
Espelt_2017,7_programs,policy_law_enforce,1_policing tactics
Espelt_2017,7_programs,policy_harm,3_SIS
Espelt_2017,8_strategies,policy_law_enforce,1_policing tactics
Espelt_2017,8_strategies,policy_harm,3_SIS
Ettner_2016,2_legislations,policy_social,2_medical insurance changes
Evans_2014,2_legislations,policy_criminal,1_drug courts
Evans_2018,3_regulation,policy_prescription,2_changes in drug formulation
Fairbarin_2015,2_legislations,policy_clinical,7_compulsory treatment
Fairbarin_2015,2_legislations,policy_clinical,9090_voluntary treatment
Falcato_2001,8_strategies,policy_law_enforce,1_policing tactics
Farrell_2005,2_legislations,policy_criminal,"9090_Forced eradication, and public punishment of transgressors"
Farrell_2005,2_legislations,policy_legislative,9090_Ban on poppy farming
Faryar_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Faryar_2017,2_legislations,policy_legislative,9090_pain clinic laws
Faryar_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Feder_2017,2_legislations,policy_social,2_medical insurance changes
Felix_2017,2_legislations,policy_legislative,3_decriminalization
Felix_2017a,2_legislations,policy_legislative,3_decriminalization
Fernandez_2018,3_regulation,policy_prescription,1_drug rescheduling
Ferrara_2012,2_legislations,policy_prescription,9090_differing regulatory approach to prescribing
Ferrara_2012,3_regulation,policy_prescription,9090_differing regulatory approach to prescribing
Filies-Away_2014,1_legal,policy_criminal,9090_Indigenous tribal wellness courts
Filies-Away_2014,7_programs,policy_criminal,9090_Indigenous tribal wellness courts
Filies-Away_2014,8_strategies,policy_criminal,9090_Indigenous tribal wellness courts
Fink_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Finley_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Fiscella_2004,5_guidelines,policy_criminal,9090_policies and guidelines around withdrawls in jail
Fiscella_2004,6_standards,policy_criminal,9090_policies and guidelines around withdrawls in jail
Fischer_2013,2_legislations,policy_legislative,1_regulation of prescription drugs
Fischer_2013,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
Fischer_2013,5_guidelines,policy_legislative,1_regulation of prescription drugs
Fischer_2013,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Fisher_2012,7_programs,policy_clinical,4_opioid prescribing standards
Fishman_2004,2_legislations,policy_legislative,1_regulation of prescription drugs
Fitzgerald_2004,7_programs,policy_law_enforce,2_police presence
Fitzgerald_2004,7_programs,policy_harm,1_needle exchange/availability
Fitzgerald_2004,7_programs,policy_harm,3_SIS
Fitzpatrick_2012,1_legal,policy_legislative,9090_Criminalization of pregnant women uses drugs
Fitzpatrick_2012,2_legislations,policy_legislative,9090_Criminalization of pregnant women uses drugs
Fleming_2019,3_regulation,policy_prescription,1_drug rescheduling
Fornili_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Franklin_2012,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Freeman_2005,7_programs,policy_harm,3_SIS
Freeman_2015,2_legislations,policy_legislative,1_regulation of prescription drugs
Freeman_2015,2_legislations,policy_legislative,9090_pain clinic laws
Freeman_2018,2_legislations,policy_harm,9090_naloxone access laws
Freeman_2018,4_government policy,policy_harm,9090_naloxone access laws
Friedman_2006,8_strategies,policy_law_enforce,2_police presence
Friedman_2006,8_strategies,policy_law_enforce,9090_# of heroin arrests
Friedman_2006,8_strategies,policy_law_enforce,9090_2_Corrections expenditures
Friedman_2017,2_legislations,policy_social,2_medical insurance changes
Friedman_2018,2_legislations,policy_social,2_medical insurance changes
Fu_2013,7_programs,policy_clinical,9090_forced methadone withdrawal
Furlan_2018,2_legislations,policy_theme,"9090_not specified in article, but mentions that regulations and clinical practice changes were included"
Furlan_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Furlan_2018,2_legislations,policy_clinical,4_opioid prescribing standards
Furlan_2018,3_regulation,policy_theme,"9090_not specified in article, but mentions that regulations and clinical practice changes were included"
Furlan_2018,3_regulation,policy_legislative,1_regulation of prescription drugs
Furlan_2018,3_regulation,policy_clinical,4_opioid prescribing standards
Furlan_2018,5_guidelines,policy_theme,"9090_not specified in article, but mentions that regulations and clinical practice changes were included"
Furlan_2018,5_guidelines,policy_legislative,1_regulation of prescription drugs
Furlan_2018,5_guidelines,policy_clinical,4_opioid prescribing standards
Garcia_2014,7_programs,policy_social,2_medical insurance changes
Garcia_2016,6_standards,policy_social,2_medical insurance changes
Garcia_2019,2_legislations,policy_social,2_medical insurance changes
Garg_2013,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Garin_2018,2_legislations,policy_legislative,4_legalization
Gau_2017,2_legislations,policy_law_enforce,1_policing tactics
Gau_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Gau_2017,8_strategies,policy_law_enforce,1_policing tactics
Gau_2017,8_strategies,policy_legislative,1_regulation of prescription drugs
Gaubert_2009,7_programs,policy_prescription,9090_Remove drug from hospital formulary
Gertner_2018,2_legislations,policy_harm,9090_naloxone access laws
Gertner_2018,4_government policy,policy_harm,9090_naloxone access laws
Ghobadi_2018,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Gillespie_2017,1_legal,policy_criminal,2_punitive charges
Gillespie_2017,1_legal,policy_criminal,9090_Criminal charges for women who use drugs while pregnant
Gillespie_2017,1_legal,policy_legislative,2_illicit drug policies
Gillespie_2017,2_legislations,policy_criminal,2_punitive charges
Gillespie_2017,2_legislations,policy_criminal,9090_Criminal charges for women who use drugs while pregnant
Gillespie_2017,2_legislations,policy_legislative,2_illicit drug policies
Gilson_2012,2_legislations,policy_legislative,1_regulation of prescription drugs
Giuntella_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Goldberg_2005,7_programs,policy_theme,9090_Establishment of pain management contract
Golichenko_2013,2_legislations,policy_law_enforce,1_policing tactics
Golichenko_2013,2_legislations,policy_harm,1_needle exchange/availability
Golichenko_2013,2_legislations,policy_legislative,2_illicit drug policies
Golichenko_2013,2_legislations,policy_clinical,7_compulsory treatment
Golichenko_2013,4_government policy,policy_law_enforce,1_policing tactics
Golichenko_2013,4_government policy,policy_harm,1_needle exchange/availability
Golichenko_2013,4_government policy,policy_legislative,2_illicit drug policies
Golichenko_2013,4_government policy,policy_clinical,7_compulsory treatment
Gomes_2012,3_regulation,policy_prescription,2_changes in drug formulation
Gomes_2014,2_legislations,policy_legislative,1_regulation of prescription drugs
Gomes_2015,2_legislations,policy_prescription,2_changes in drug formulation
Gomes_2017,3_regulation,policy_prescription,2_changes in drug formulation
Gomes_2018,3_regulation,policy_prescription,2_changes in drug formulation
Goncalves_2015,8_strategies,policy_harm,1_needle exchange/availability
Goncalves_2015,8_strategies,policy_legislative,3_decriminalization
Goncalves_2015,8_strategies,policy_clinical,1_availability of OAT
Gonzalez_2012,2_legislations,policy_legislative,1_regulation of prescription drugs
Goodman_2008,2_legislations,policy_legislative,1_regulation of prescription drugs
Goodwin_2014,2_legislations,policy_law_enforce,1_policing tactics
Goodwin_2014,2_legislations,policy_criminal,2_punitive charges
Goodwin_2014,2_legislations,policy_legislative,9090_criminalizing drug use while prenanacy and requiring clinician reporting
Goodwin_2014,3_regulation,policy_law_enforce,1_policing tactics
Goodwin_2014,3_regulation,policy_criminal,2_punitive charges
Goodwin_2014,3_regulation,policy_legislative,9090_criminalizing drug use while prenanacy and requiring clinician reporting
Gordon_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
Gordon_2016,2_legislations,policy_clinical,1_availability of OAT
Gordon_2016,2_legislations,policy_prescription,1_drug rescheduling
Gordon_2016,3_regulation,policy_legislative,1_regulation of prescription drugs
Gordon_2016,3_regulation,policy_clinical,1_availability of OAT
Gordon_2016,3_regulation,policy_prescription,1_drug rescheduling
Graddy_2017,7_programs,policy_prescription,2_changes in drug formulation
Grant_2017,2_legislations,policy_legislative,4_legalization
Grecu_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Green_2006,2_legislations,policy_social,9090_Adoption and safe families act
Green_2012,2_legislations,policy_legislative,1_regulation of prescription drugs
Greenwald_2009,2_legislations,policy_legislative,3_decriminalization
Grogan_2016,2_legislations,policy_social,2_medical insurance changes
Gutheil_2016,2_legislations,policy_harm,1_needle exchange/availability
Gutheil_2016,2_legislations,policy_harm,3_SIS
Gutheil_2016,2_legislations,policy_criminal,2_punitive charges
Gutheil_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
Gutheil_2016,2_legislations,policy_legislative,2_illicit drug policies
Gutheil_2016,2_legislations,policy_legislative,3_decriminalization
Gutheil_2016,2_legislations,policy_legislative,4_legalization
Gutheil_2016,2_legislations,policy_clinical,1_availability of OAT
Gutheil_2016,2_legislations,policy_international,1_international drug treaties
Gutheil_2016,2_legislations,policy_international,9090_mechanisims to operatinalize international EU commitments
Gutheil_2016,3_regulation,policy_harm,1_needle exchange/availability
Gutheil_2016,3_regulation,policy_harm,3_SIS
Gutheil_2016,3_regulation,policy_criminal,2_punitive charges
Gutheil_2016,3_regulation,policy_legislative,1_regulation of prescription drugs
Gutheil_2016,3_regulation,policy_legislative,2_illicit drug policies
Gutheil_2016,3_regulation,policy_legislative,3_decriminalization
Gutheil_2016,3_regulation,policy_legislative,4_legalization
Gutheil_2016,3_regulation,policy_clinical,1_availability of OAT
Gutheil_2016,3_regulation,policy_international,1_international drug treaties
Gutheil_2016,3_regulation,policy_international,9090_mechanisims to operatinalize international EU commitments
Gutheil_2016,8_strategies,policy_harm,1_needle exchange/availability
Gutheil_2016,8_strategies,policy_harm,3_SIS
Gutheil_2016,8_strategies,policy_criminal,2_punitive charges
Gutheil_2016,8_strategies,policy_legislative,1_regulation of prescription drugs
Gutheil_2016,8_strategies,policy_legislative,2_illicit drug policies
Gutheil_2016,8_strategies,policy_legislative,3_decriminalization
Gutheil_2016,8_strategies,policy_legislative,4_legalization
Gutheil_2016,8_strategies,policy_clinical,1_availability of OAT
Gutheil_2016,8_strategies,policy_international,1_international drug treaties
Gutheil_2016,8_strategies,policy_international,9090_mechanisims to operatinalize international EU commitments
Habbouche_2018,3_regulation,policy_prescription,1_drug rescheduling
Haegerich_2014,2_legislations,policy_harm,9090_naloxone distribution and overdose prevention/response education
Haegerich_2014,2_legislations,policy_legislative,1_regulation of prescription drugs
Haegerich_2014,2_legislations,policy_legislative,5_first responders
Haegerich_2014,2_legislations,policy_clinical,4_opioid prescribing standards
Haegerich_2014,3_regulation,policy_harm,9090_naloxone distribution and overdose prevention/response education
Haegerich_2014,3_regulation,policy_legislative,1_regulation of prescription drugs
Haegerich_2014,3_regulation,policy_legislative,5_first responders
Haegerich_2014,3_regulation,policy_clinical,4_opioid prescribing standards
Haegerich_2014,4_government policy,policy_harm,9090_naloxone distribution and overdose prevention/response education
Haegerich_2014,4_government policy,policy_legislative,1_regulation of prescription drugs
Haegerich_2014,4_government policy,policy_legislative,5_first responders
Haegerich_2014,4_government policy,policy_clinical,4_opioid prescribing standards
Haegerich_2014,5_guidelines,policy_harm,9090_naloxone distribution and overdose prevention/response education
Haegerich_2014,5_guidelines,policy_legislative,1_regulation of prescription drugs
Haegerich_2014,5_guidelines,policy_legislative,5_first responders
Haegerich_2014,5_guidelines,policy_clinical,4_opioid prescribing standards
Haegerich_2014,7_programs,policy_harm,9090_naloxone distribution and overdose prevention/response education
Haegerich_2014,7_programs,policy_legislative,1_regulation of prescription drugs
Haegerich_2014,7_programs,policy_legislative,5_first responders
Haegerich_2014,7_programs,policy_clinical,4_opioid prescribing standards
Haegerich_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Haegerich_2019,2_legislations,policy_legislative,5_first responders
Haegerich_2019,2_legislations,policy_social,2_medical insurance changes
Haegerich_2019,2_legislations,policy_clinical,2_availability of OAT - provider - doctors
Haegerich_2019,4_government policy,policy_legislative,1_regulation of prescription drugs
Haegerich_2019,4_government policy,policy_legislative,5_first responders
Haegerich_2019,4_government policy,policy_social,2_medical insurance changes
Haegerich_2019,4_government policy,policy_clinical,2_availability of OAT - provider - doctors
Haegerich_2019,5_guidelines,policy_legislative,1_regulation of prescription drugs
Haegerich_2019,5_guidelines,policy_legislative,5_first responders
Haegerich_2019,5_guidelines,policy_social,2_medical insurance changes
Haegerich_2019,5_guidelines,policy_clinical,2_availability of OAT - provider - doctors
Haffajee_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Hammett_2014,2_legislations,policy_harm,1_needle exchange/availability
Hammett_2014,2_legislations,policy_harm,"9090_BBI testing/vaccination, SSTI treatment"
Hammett_2014,2_legislations,policy_clinical,3_availability of OAT - provider - pharmacists
Hammett_2014,3_regulation,policy_harm,1_needle exchange/availability
Hammett_2014,3_regulation,policy_harm,"9090_BBI testing/vaccination, SSTI treatment"
Hammett_2014,3_regulation,policy_clinical,3_availability of OAT - provider - pharmacists
Hammett_2014,4_government policy,policy_harm,1_needle exchange/availability
Hammett_2014,4_government policy,policy_harm,"9090_BBI testing/vaccination, SSTI treatment"
Hammett_2014,4_government policy,policy_clinical,3_availability of OAT - provider - pharmacists
Hampton_2011,2_legislations,policy_clinical,7_compulsory treatment
Hansen_2017,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Hansen_2017,7_programs,policy_clinical,5_opioid prescribing standards - provider - doctor
Hardjasa_2018,2_legislations,policy_legislative,2_illicit drug policies
Harrison_2019,3_regulation,policy_prescription,1_drug rescheduling
Hartung_2004,2_legislations,policy_social,2_medical insurance changes
Hartung_2017,3_regulation,policy_social,2_medical insurance changes
Hartung_2018,5_guidelines,policy_clinical,1_availability of OAT
Hartung_2018,5_guidelines,policy_clinical,4_opioid prescribing standards
Hartung_2018,7_programs,policy_clinical,1_availability of OAT
Hartung_2018,7_programs,policy_clinical,4_opioid prescribing standards
Havens_2014,3_regulation,policy_prescription,2_changes in drug formulation
Hawton_2009,3_regulation,policy_prescription,3_withdraw drug
Hawton_2011,3_regulation,policy_prescription,3_withdraw drug
Hawton_2012,3_regulation,policy_prescription,3_withdraw drug
Hayashi_2013,4_government policy,policy_law_enforce,1_policing tactics
Hayes_2015,3_regulation,policy_prescription,3_withdraw drug
Haynes_2016,3_regulation,policy_prescription,1_drug rescheduling
Hedrich_2012,7_programs,policy_clinical,1_availability of OAT
Heins_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Heins_2019,2_legislations,policy_prescription,9090_Morphine Equivalent Daily Dose policies
Heins_2019,4_government policy,policy_legislative,1_regulation of prescription drugs
Heins_2019,4_government policy,policy_prescription,9090_Morphine Equivalent Daily Dose policies
Heins_2019,5_guidelines,policy_legislative,1_regulation of prescription drugs
Heins_2019,5_guidelines,policy_prescription,9090_Morphine Equivalent Daily Dose policies
Henderson_2016,2_legislations,policy_legislative,3_decriminalization
Henderson_2016,2_legislations,policy_international,1_international drug treaties
Hewlett_2013,2_legislations,policy_legislative,1_regulation of prescription drugs
Hoffman_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Homenko_2009,3_regulation,policy_legislative,1_regulation of prescription drugs
Hopwood_2003,4_government policy,policy_harm,1_needle exchange/availability
Hopwood_2003,4_government policy,policy_harm,9090_specifically removal of supplies for methadone injection
Hora_2008,2_legislations,policy_criminal,1_drug courts
Horgan_2008,5_guidelines,policy_clinical,1_availability of OAT
Houborg_2014b,8_strategies,policy_law_enforce,1_policing tactics
Hough_2003,2_legislations,policy_clinical,7_compulsory treatment
Hser_2003,2_legislations,policy_criminal,1_drug courts
Hser_2007,2_legislations,policy_clinical,7_compulsory treatment
Huey_2019,7_programs,policy_harm,3_SIS
Hughes_2007,2_legislations,policy_legislative,3_decriminalization
Hughes_2018,2_legislations,policy_criminal,9090_2_police diversion
Hughes_2018,2_legislations,policy_legislative,3_decriminalization
Hughes_2018,2_legislations,policy_legislative,9090_depenalization
Hughes_2018,3_regulation,policy_criminal,9090_2_police diversion
Hughes_2018,3_regulation,policy_legislative,3_decriminalization
Hughes_2018,3_regulation,policy_legislative,9090_depenalization
Husain_2014,2_legislations,policy_legislative,2_illicit drug policies
Husain_2014,2_legislations,policy_international,1_international drug treaties
Hwang_2015,3_regulation,policy_prescription,2_changes in drug formulation
Inciardi_2003,8_strategies,policy_criminal,1_drug courts
Inciardi_2003,8_strategies,policy_legislative,2_illicit drug policies
Inciardi_2009,4_government policy,policy_legislative,9090_FDA approval of generic drugs
Irvine_2019,3_regulation,policy_harm,4_OPS
Irvine_2019,3_regulation,policy_harm,9090_take home nalaxone kits
Irvine_2019,3_regulation,policy_clinical,1_availability of OAT
Irvine_2019,7_programs,policy_harm,4_OPS
Irvine_2019,7_programs,policy_harm,9090_take home nalaxone kits
Irvine_2019,7_programs,policy_clinical,1_availability of OAT
Irwin_2017,7_programs,policy_harm,3_SIS
Israelsson_2011,2_legislations,policy_criminal,9090_compulsory commitment to care
Israelsson_2011,2_legislations,policy_clinical,7_compulsory treatment
Israelsson_2012_2,2_legislations,policy_criminal,9090_compulsory commitment to care
Israelsson_2012_2,2_legislations,policy_clinical,7_compulsory treatment
Israelsson_2015,2_legislations,policy_criminal,9090_compulsory commitment to care
Israelsson_2015,2_legislations,policy_clinical,7_compulsory treatment
Jauncey_2018,3_regulation,policy_prescription,2_changes in drug formulation
Johnson_2006,7_programs,policy_harm,1_needle exchange/availability
Johnson_2011,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Jozaghi_2013,2_legislations,policy_harm,3_SIS
Junod_2018,1_legal,policy_clinical,1_availability of OAT
Kaestner_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Kahler_2017,7_programs,policy_clinical,9090_Decline to prescribe opioids in ED and referral to pain clinic
Kampschmidt_2015,2_legislations,policy_criminal,2_punitive charges
Kampschmidt_2015,2_legislations,policy_legislative,9090_Fetal protection criminal statutes
Kampschmidt_2015,8_strategies,policy_criminal,2_punitive charges
Kampschmidt_2015,8_strategies,policy_legislative,9090_Fetal protection criminal statutes
Kattan_2016,7_programs,policy_clinical,5_opioid prescribing standards - provider - doctor
Katz_2009,7_programs,policy_legislative,2_illicit drug policies
Katz_2009,7_programs,policy_clinical,9090_avaliability of prescription heroin
Katz_2009,8_strategies,policy_legislative,2_illicit drug policies
Katz_2009,8_strategies,policy_clinical,9090_avaliability of prescription heroin
Kaufman_2019,2_legislations,policy_legislative,4_legalization
Keast_2016,3_regulation,policy_prescription,2_changes in drug formulation
Keast_2017,3_regulation,policy_prescription,2_changes in drug formulation
Keast_2018,3_regulation,policy_social,2_medical insurance changes
Keene_2007,7_programs,policy_clinical,1_availability of OAT
Kennedy-Hendrick_2016,2_legislations,policy_criminal,9090_arrest and prosecution those involved with 'pill mills'
Kennedy-Hendrick_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
Kennedy_2017,7_programs,policy_harm,3_SIS
Kennedy_2019,5_guidelines,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Kennedy_2019,6_standards,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Kerr_2006,7_programs,policy_harm,3_SIS
Khobrani_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Khruakham_2016,8_strategies,policy_law_enforce,1_policing tactics
Khruakham_2016,8_strategies,policy_criminal,2_punitive charges
Khruakham_2016,8_strategies,policy_legislative,9090_control of illicit drugs through monitoring of chemicals and precursors
Khruakham_2016,8_strategies,policy_social,9090_Reintegrative programs - job opportunities and vocational training
Khruakham_2016,8_strategies,policy_clinical,7_compulsory treatment
Kilby_2015,2_legislations,policy_legislative,1_regulation of prescription drugs
Kim_2016,2_legislations,policy_legislative,4_legalization
Kinnard_2014,2_legislations,policy_harm,3_SIS
Kinner_2013,4_government policy,policy_clinical,1_availability of OAT
Kinsman_2018,2_legislations,policy_prescription,9090_authority to administer Naloxone by EMTs
Kinsman_2018,3_regulation,policy_prescription,9090_authority to administer Naloxone by EMTs
Kline_2019,7_programs,policy_clinical,5_opioid prescribing standards - provider - doctor
Knudsen_2015,2_legislations,policy_social,2_medical insurance changes
Knudsen_2015a,3_regulation,policy_social,2_medical insurance changes
Knudsen_2017,2_legislations,policy_social,2_medical insurance changes
Knudsen_2019,2_legislations,policy_social,2_medical insurance changes
Kopf_2014,2_legislations,policy_law_enforce,2_police presence
Kopf_2014,2_legislations,policy_legislative,5_first responders
Korn_2016,1_legal,policy_criminal,2_punitive charges
Korn_2016,1_legal,policy_legislative,2_illicit drug policies
Korn_2016,1_legal,policy_social,9090_Child protective services
Korn_2016,2_legislations,policy_criminal,2_punitive charges
Korn_2016,2_legislations,policy_legislative,2_illicit drug policies
Korn_2016,2_legislations,policy_social,9090_Child protective services
Kozhimannil_2019,3_regulation,policy_criminal,1_drug courts
Kozhimannil_2019,3_regulation,policy_criminal,2_punitive charges
Kozhimannil_2019,3_regulation,policy_legislative,9090_provider reporting requirements
Kozhimannil_2019,3_regulation,policy_clinical,1_availability of OAT
Kozhimannil_2019,4_government policy,policy_criminal,1_drug courts
Kozhimannil_2019,4_government policy,policy_criminal,2_punitive charges
Kozhimannil_2019,4_government policy,policy_legislative,9090_provider reporting requirements
Kozhimannil_2019,4_government policy,policy_clinical,1_availability of OAT
Krakauer_2015,3_regulation,policy_legislative,1_regulation of prescription drugs
Krakauer_2015,3_regulation,policy_clinical,4_opioid prescribing standards
Krakauer_2015,7_programs,policy_legislative,1_regulation of prescription drugs
Krakauer_2015,7_programs,policy_clinical,4_opioid prescribing standards
Kramer_2015,4_government policy,policy_criminal,2_punitive charges
Kropp_2019,2_legislations,policy_legislative,4_legalization
Kruithof_2017,2_legislations,policy_criminal,1_drug courts
Kruithof_2017,2_legislations,policy_criminal,9090_other types of diversion
Kruithof_2017,2_legislations,policy_clinical,7_compulsory treatment
Kumar_2019,3_regulation,policy_prescription,2_changes in drug formulation
Kuo_2018,3_regulation,policy_prescription,1_drug rescheduling
Kushel_2017,3_regulation,policy_prescription,1_drug rescheduling
Kwok_2017,4_government policy,policy_prescription,9090_Prior authorization program
Ladd_2017,3_regulation,policy_theme,9090_NP scope of practice
Ladd_2017,3_regulation,policy_clinical,2_availability of OAT - provider - doctors
Lambdin_2018,2_legislations,policy_harm,9090_naloxone access laws
Lambdin_2018,4_government policy,policy_harm,9090_naloxone access laws
Larance_2015,3_regulation,policy_prescription,2_changes in drug formulation
Larance_2015_2,3_regulation,policy_prescription,2_changes in drug formulation
Larance_2018,3_regulation,policy_prescription,2_changes in drug formulation
Larkin_2016,1_legal,policy_criminal,1_drug courts
Larkin_2016,1_legal,policy_criminal,2_punitive charges
Larkin_2016,1_legal,policy_theme,9090_Probation
Larkin_2016,2_legislations,policy_criminal,1_drug courts
Larkin_2016,2_legislations,policy_criminal,2_punitive charges
Larkin_2016,2_legislations,policy_theme,9090_Probation
Larochelle_2015,2_legislations,policy_prescription,2_changes in drug formulation
Larochelle_2015,2_legislations,policy_prescription,3_withdraw drug
Lasnier_2010,2_legislations,policy_legislative,2_illicit drug policies
Lasnier_2010,2_legislations,policy_clinical,1_availability of OAT
Latimore_2017,2_legislations,policy_legislative,5_first responders
Laws_2005,4_government policy,policy_clinical,1_availability of OAT
Levy_2008,1_legal,policy_criminal,2_punitive charges
Levy_2008,1_legal,policy_legislative,2_illicit drug policies
Levy_2008,2_legislations,policy_criminal,2_punitive charges
Levy_2008,2_legislations,policy_legislative,2_illicit drug policies
Li_2014,2_legislations,policy_legislative,1_regulation of prescription drugs
Liang_2018,2_legislations,policy_legislative,4_legalization
Liang_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Liang_2019_2,2_legislations,policy_legislative,4_legalization
Liang_2019_2,2_legislations,policy_clinical,2_availability of OAT - provider - doctors
Lilley_2013,2_legislations,policy_criminal,1_drug courts
Lilley_2016,2_legislations,policy_criminal,1_drug courts
Lilley_2019,2_legislations,policy_criminal,1_drug courts
Lin_2017,7_programs,policy_clinical,9090_dashboard that notes high dose opioid prescribing and concurrent benzodiazepine use
Lin_2017_2,2_legislations,policy_legislative,1_regulation of prescription drugs
Lin_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Lin_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Liu_2019,3_regulation,policy_prescription,1_drug rescheduling
Livingstone_2017,2_legislations,policy_legislative,4_legalization
Lloyd_2017,2_legislations,policy_harm,3_SIS
Lo_2018,2_legislations,policy_legislative,4_legalization
Lofgren_2011,2_legislations,policy_criminal,1_drug courts
Lofgren_2011,2_legislations,policy_criminal,9090_other drug reform laws that focused on treatment instead of incarceration
Lofgren_2011,3_regulation,policy_criminal,1_drug courts
Lofgren_2011,3_regulation,policy_criminal,9090_other drug reform laws that focused on treatment instead of incarceration
Logan_2001,2_legislations,policy_criminal,1_drug courts
Lollar_2017,1_legal,policy_criminal,2_punitive charges
Lollar_2017,2_legislations,policy_criminal,2_punitive charges
Loong_2019,2_legislations,policy_criminal,9090_mental health courts
Losby_2016,7_programs,policy_clinical,5_opioid prescribing standards - provider - doctor
Lucas_2017,3_regulation,policy_legislative,1_regulation of prescription drugs
Luyt_2007,5_guidelines,policy_harm,1_needle exchange/availability
Luyt_2007,5_guidelines,policy_harm,5_drug testing
Luyt_2007,5_guidelines,policy_criminal,2_punitive charges
Luyt_2007,5_guidelines,policy_clinical,1_availability of OAT
Luyt_2007,7_programs,policy_harm,1_needle exchange/availability
Luyt_2007,7_programs,policy_harm,5_drug testing
Luyt_2007,7_programs,policy_criminal,2_punitive charges
Luyt_2007,7_programs,policy_clinical,1_availability of OAT
Lyapustina_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
Macdonald_2001a,2_legislations,policy_social,3_restrictions
MacDonald_2019,7_programs,policy_theme,9090_doctor shopping - letters sent to prescribers for that were identified as receiving opioids from more than 3 prescribers/pharmacies
MacDonald_2019,7_programs,policy_legislative,1_regulation of prescription drugs
MacLean_2018,5_guidelines,policy_clinical,4_opioid prescribing standards
MacLean_2018_2,2_legislations,policy_social,2_medical insurance changes
Majtabai_2018,2_legislations,policy_social,2_medical insurance changes
Malkin_2001,2_legislations,policy_harm,3_SIS
Malkin_2001,2_legislations,policy_international,1_international drug treaties
Malkin_2001,4_government policy,policy_harm,3_SIS
Malkin_2001,4_government policy,policy_international,1_international drug treaties
Malkin_2001,7_programs,policy_harm,3_SIS
Malkin_2001,7_programs,policy_international,1_international drug treaties
Mallatt_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Mallatt_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Mallatt_2019_2,2_legislations,policy_legislative,1_regulation of prescription drugs
Mallatt_2019_2,2_legislations,policy_prescription,2_changes in drug formulation
Mallatt_2019_2,3_regulation,policy_legislative,1_regulation of prescription drugs
Mallatt_2019_2,3_regulation,policy_prescription,2_changes in drug formulation
Mallya_2013,7_programs,policy_clinical,9090_witnessed vs unwitnessed urine drug screens
Mandiberg_2014,2_legislations,policy_legislative,9090_Federal housing law
Mandiberg_2014,2_legislations,policy_legislative,9090_2_Rehabilitation act (RA)
Mandiberg_2014,2_legislations,policy_legislative,9090_3_Americans with disabilities act (ADA)
Mandiberg_2014,7_programs,policy_legislative,9090_Federal housing law
Mandiberg_2014,7_programs,policy_legislative,9090_2_Rehabilitation act (RA)
Mandiberg_2014,7_programs,policy_legislative,9090_3_Americans with disabilities act (ADA)
Margolis_2009,4_government policy,policy_social,2_medical insurance changes
Margolis_2010,6_standards,policy_social,2_medical insurance changes
Marotta_2016,7_programs,policy_harm,1_needle exchange/availability
Marotta_2016,7_programs,policy_clinical,1_availability of OAT
Marshall_2011,7_programs,policy_harm,3_SIS
Martello_2018,7_programs,policy_legislative,1_regulation of prescription drugs
Martin_2018,3_regulation,policy_prescription,1_drug rescheduling
Martinez_2007,2_legislations,policy_harm,1_needle exchange/availability
Maughan_2015,2_legislations,policy_legislative,1_regulation of prescription drugs
Mazerolle_2006,8_strategies,policy_law_enforce,1_policing tactics
McAuley_2015,7_programs,policy_harm,9090_Take home naloxone
McAuley_2017,7_programs,policy_harm,9090_national naloxone programme
McCary_2019,2_legislations,policy_social,2_medical insurance changes
McClellan_2018,2_legislations,policy_harm,9090_naloxone access laws
McClellan_2018,2_legislations,policy_legislative,5_first responders
McClellan_2018,4_government policy,policy_harm,9090_naloxone access laws
McClellan_2018,4_government policy,policy_legislative,5_first responders
McClure_2019,1_legal,policy_criminal,9090_prosecution of doctors for chronically over-prescribing opioids (pill mills)
McConnell_2012,2_legislations,policy_social,2_medical insurance changes
McConnell_2012_2,3_regulation,policy_social,2_medical insurance changes
McFarland_2005,4_government policy,policy_social,2_medical insurance changes
McGerald_2009,7_programs,policy_theme,9090_Streamlined prescribing writing process
McGinty_2015,2_legislations,policy_social,2_medical insurance changes
McInerney_2019,7_programs,policy_social,2_medical insurance changes
McKenna_2017,2_legislations,policy_social,2_medical insurance changes
McKenzie_2005,7_programs,policy_clinical,1_availability of OAT
McMichael_2018,2_legislations,policy_legislative,4_legalization
McMichael_2018_2,3_regulation,policy_theme,9090_NP scope of practice
McMichael_2018_2,3_regulation,policy_clinical,2_availability of OAT - provider - doctors
McSweeny_2007,2_legislations,policy_clinical,7_compulsory treatment
McSweeny_2007,4_government policy,policy_clinical,7_compulsory treatment
Meara_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
Meinhofer_2018,2_legislations,policy_social,2_medical insurance changes
Meinhofer_2019,2_legislations,policy_legislative,4_legalization
Meisenberg_2018,7_programs,policy_clinical,9090_Physician and public education
Merlo_2011,2_legislations,policy_clinical,7_compulsory treatment
Meyerson_2018,4_government policy,policy_harm,9090_naloxone access laws
Michels_2007,4_government policy,policy_clinical,1_availability of OAT
Miller_2004,7_programs,policy_clinical,9090_Prescription heroin
Miller_2016,2_legislations,policy_legislative,5_first responders
Miller_2016,2_legislations,policy_legislative,9090_State-based opioid overdose response program
Miller_2016,5_guidelines,policy_legislative,5_first responders
Miller_2016,5_guidelines,policy_legislative,9090_State-based opioid overdose response program
Milloy_2008,7_programs,policy_harm,3_SIS
Minhee_2019,8_strategies,policy_legislative,2_illicit drug policies
Miron_2003,2_legislations,policy_legislative,4_legalization
Mitchell_2012,1_legal,policy_criminal,1_drug courts
Mitchell_2012_2,7_programs,policy_criminal,1_drug courts
Mohammadi_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Mojtabai_2019,2_legislations,policy_social,2_medical insurance changes
Mojtabai_2019b,2_legislations,policy_social,2_medical insurance changes
Monaghan_2013,7_programs,policy_social,9090_Welfare-to-work program
Moore_2007,7_programs,policy_criminal,9090_prison
Moore_2007,7_programs,policy_clinical,1_availability of OAT
Moore_2007,7_programs,policy_clinical,7_compulsory treatment
Morden_2008,2_legislations,policy_social,2_medical insurance changes
Morgan_2015,2_legislations,policy_social,2_medical insurance changes
Moride_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Moride_2019,2_legislations,policy_prescription,1_drug rescheduling
Moride_2019,3_regulation,policy_legislative,1_regulation of prescription drugs
Moride_2019,3_regulation,policy_prescription,1_drug rescheduling
Morse_2011,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Mospan_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Mospan_2018,2_legislations,policy_social,2_medical insurance changes
Mospan_2018,8_strategies,policy_legislative,1_regulation of prescription drugs
Mospan_2018,8_strategies,policy_social,2_medical insurance changes
Moyo_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Moyo_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Mulcahy_2017,3_regulation,policy_prescription,9090_Creation of a formulary
Mulrooney_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Murimi_2019,3_regulation,policy_prescription,1_drug rescheduling
Murphy_2017,7_programs,policy_clinical,9090_ED care coordination program
Musselwhite_2010,1_legal,policy_criminal,2_punitive charges
Musselwhite_2010,1_legal,policy_legislative,2_illicit drug policies
Musselwhite_2010,2_legislations,policy_criminal,2_punitive charges
Musselwhite_2010,2_legislations,policy_legislative,2_illicit drug policies
Myer_2018,7_programs,policy_harm,3_SIS
Nagar_2015,2_legislations,policy_legislative,1_regulation of prescription drugs
Nagar_2015,2_legislations,policy_legislative,9090_pain clinic laws
Nam_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Naumann_2018,3_regulation,policy_social,2_medical insurance changes
Naumann_2018_2,7_programs,policy_social,2_medical insurance changes
Naumann_2019,7_programs,policy_social,2_medical insurance changes
Neven_2016,7_programs,policy_clinical,9090_ED care coordination program
Nguyen_2018,2_legislations,policy_legislative,5_first responders
Nicosia_2017,2_legislations,policy_criminal,1_drug courts
Niv_2009,2_legislations,policy_criminal,1_drug courts
Nordt_2009,7_programs,policy_clinical,1_availability of OAT
Nordt_2010,7_programs,policy_law_enforce,1_policing tactics
Nordt_2010,7_programs,policy_clinical,1_availability of OAT
Northrup_2019,3_regulation,policy_prescription,1_drug rescheduling
Novak_2012,2_legislations,policy_criminal,2_punitive charges
Obadia_2001,4_government policy,policy_clinical,2_availability of OAT - provider - doctors
Obrien_2013,2_legislations,policy_legislative,1_regulation of prescription drugs
OConner_2011,2_legislations,policy_legislative,1_regulation of prescription drugs
OConnor_2019,1_legal,policy_criminal,1_drug courts
OConnor_2019,7_programs,policy_criminal,1_drug courts
Oehler_2016,3_regulation,policy_prescription,1_drug rescheduling
Olfson_2018,2_legislations,policy_social,2_medical insurance changes
Olsen_2006,2_legislations,policy_harm,3_SIS
Olson_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Olson_2019,2_legislations,policy_legislative,4_legalization
Olson_2019,2_legislations,policy_legislative,5_first responders
Olson_2019,2_legislations,policy_legislative,9090_Nalxone access law
Olson_2019,2_legislations,policy_legislative,9090_2_pain clinic laws
Olson_2019,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
Olson_2019,3_regulation,policy_legislative,1_regulation of prescription drugs
Olson_2019,3_regulation,policy_legislative,4_legalization
Olson_2019,3_regulation,policy_legislative,5_first responders
Olson_2019,3_regulation,policy_legislative,9090_Nalxone access law
Olson_2019,3_regulation,policy_legislative,9090_2_pain clinic laws
Olson_2019,3_regulation,policy_clinical,5_opioid prescribing standards - provider - doctor
Olson_2019,5_guidelines,policy_legislative,1_regulation of prescription drugs
Olson_2019,5_guidelines,policy_legislative,4_legalization
Olson_2019,5_guidelines,policy_legislative,5_first responders
Olson_2019,5_guidelines,policy_legislative,9090_Nalxone access law
Olson_2019,5_guidelines,policy_legislative,9090_2_pain clinic laws
Olson_2019,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Osborn_2017,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Ozluk_2017,2_legislations,policy_legislative,4_legalization
Page_2018,7_programs,policy_clinical,5_opioid prescribing standards - provider - doctor
Palmateer_2014,7_programs,policy_harm,1_needle exchange/availability
Palmateer_2014,7_programs,policy_harm,9090_other clean paraphinalia
Palmateer_2014,7_programs,policy_clinical,1_availability of OAT
Paone_2015,2_legislations,policy_legislative,1_regulation of prescription drugs
Paone_2015,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
Paone_2015,5_guidelines,policy_legislative,1_regulation of prescription drugs
Paone_2015,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Paone_2015,8_strategies,policy_legislative,1_regulation of prescription drugs
Paone_2015,8_strategies,policy_clinical,5_opioid prescribing standards - provider - doctor
Pardo_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Pardo_2017,2_legislations,policy_legislative,4_legalization
Park_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Parsons_2014,2_legislations,policy_criminal,1_drug courts
Parsons_2014,2_legislations,policy_criminal,9090_Changes in mandatory sentencing structure
Patrick_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
Paulozzi_2011,2_legislations,policy_legislative,1_regulation of prescription drugs
Pauly_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Peacock_2015,3_regulation,policy_prescription,2_changes in drug formulation
Peakcock_2015,3_regulation,policy_prescription,2_changes in drug formulation
Pearson_2015,3_regulation,policy_prescription,2_changes in drug formulation
Pedersen_2011,4_government policy,policy_clinical,1_availability of OAT
Pedersen_2011,4_government policy,policy_clinical,9090_Mandate that treatment (OAT or residential) must begin within 14 days after a request
Penm_2017,2_legislations,policy_harm,9090_naloxone access laws
Penm_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Penm_2017,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
Penm_2017,2_legislations,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Penm_2017,4_government policy,policy_harm,9090_naloxone access laws
Penm_2017,4_government policy,policy_legislative,1_regulation of prescription drugs
Penm_2017,4_government policy,policy_clinical,5_opioid prescribing standards - provider - doctor
Penm_2017,4_government policy,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Penm_2017,5_guidelines,policy_harm,9090_naloxone access laws
Penm_2017,5_guidelines,policy_legislative,1_regulation of prescription drugs
Penm_2017,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Penm_2017,5_guidelines,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Perez-Munoz_2017,2_legislations,policy_social,1_welfare expansion/reform
Perngmark_2007,2_legislations,policy_law_enforce,1_policing tactics
Perngmark_2007,2_legislations,policy_legislative,2_illicit drug policies
Perngmark_2007,2_legislations,policy_clinical,1_availability of OAT
Perngmark_2007,2_legislations,policy_clinical,7_compulsory treatment
Perngmark_2007,4_government policy,policy_law_enforce,1_policing tactics
Perngmark_2007,4_government policy,policy_legislative,2_illicit drug policies
Perngmark_2007,4_government policy,policy_clinical,1_availability of OAT
Perngmark_2007,4_government policy,policy_clinical,7_compulsory treatment
Perry_2009,7_programs,policy_criminal,1_drug courts
Peterson_2019,2_legislations,policy_criminal,2_punitive charges
Phillips_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Phillips_2017,2_legislations,policy_legislative,4_legalization
Pinkerton_2010,7_programs,policy_harm,3_SIS
Pitt_2018,2_legislations,policy_harm,1_needle exchange/availability
Pitt_2018,2_legislations,policy_harm,9090_naloxone access laws
Pitt_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Pitt_2018,2_legislations,policy_clinical,1_availability of OAT
Pitt_2018,2_legislations,policy_clinical,4_opioid prescribing standards
Pitt_2018,2_legislations,policy_prescription,1_drug rescheduling
Pitt_2018,2_legislations,policy_prescription,2_changes in drug formulation
Pitt_2018,2_legislations,policy_prescription,9090_Excess drug disposal
Pitt_2018,3_regulation,policy_harm,1_needle exchange/availability
Pitt_2018,3_regulation,policy_harm,9090_naloxone access laws
Pitt_2018,3_regulation,policy_legislative,1_regulation of prescription drugs
Pitt_2018,3_regulation,policy_clinical,1_availability of OAT
Pitt_2018,3_regulation,policy_clinical,4_opioid prescribing standards
Pitt_2018,3_regulation,policy_prescription,1_drug rescheduling
Pitt_2018,3_regulation,policy_prescription,2_changes in drug formulation
Pitt_2018,3_regulation,policy_prescription,9090_Excess drug disposal
Pitt_2018,4_government policy,policy_harm,1_needle exchange/availability
Pitt_2018,4_government policy,policy_harm,9090_naloxone access laws
Pitt_2018,4_government policy,policy_legislative,1_regulation of prescription drugs
Pitt_2018,4_government policy,policy_clinical,1_availability of OAT
Pitt_2018,4_government policy,policy_clinical,4_opioid prescribing standards
Pitt_2018,4_government policy,policy_prescription,1_drug rescheduling
Pitt_2018,4_government policy,policy_prescription,2_changes in drug formulation
Pitt_2018,4_government policy,policy_prescription,9090_Excess drug disposal
Pitt_2018,5_guidelines,policy_harm,1_needle exchange/availability
Pitt_2018,5_guidelines,policy_harm,9090_naloxone access laws
Pitt_2018,5_guidelines,policy_legislative,1_regulation of prescription drugs
Pitt_2018,5_guidelines,policy_clinical,1_availability of OAT
Pitt_2018,5_guidelines,policy_clinical,4_opioid prescribing standards
Pitt_2018,5_guidelines,policy_prescription,1_drug rescheduling
Pitt_2018,5_guidelines,policy_prescription,2_changes in drug formulation
Pitt_2018,5_guidelines,policy_prescription,9090_Excess drug disposal
Pitt_2018,7_programs,policy_harm,1_needle exchange/availability
Pitt_2018,7_programs,policy_harm,9090_naloxone access laws
Pitt_2018,7_programs,policy_legislative,1_regulation of prescription drugs
Pitt_2018,7_programs,policy_clinical,1_availability of OAT
Pitt_2018,7_programs,policy_clinical,4_opioid prescribing standards
Pitt_2018,7_programs,policy_prescription,1_drug rescheduling
Pitt_2018,7_programs,policy_prescription,2_changes in drug formulation
Pitt_2018,7_programs,policy_prescription,9090_Excess drug disposal
Pohl_2018,2_legislations,policy_harm,9090_naloxone
Pohl_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Pohl_2018,2_legislations,policy_legislative,4_legalization
Pohl_2018,2_legislations,policy_legislative,5_first responders
Pombo_2016,2_legislations,policy_legislative,3_decriminalization
Ponnapalli_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Popovici_2018,3_regulation,policy_theme,9090_2_doctor shopping laws
Popovici_2018,3_regulation,policy_legislative,9090_pain clinic laws
Popovici_2018_2,2_legislations,policy_social,2_medical insurance changes
Potier_2014,3_regulation,policy_harm,3_SIS
Powell_2011,3_regulation,policy_clinical,7_compulsory treatment
Powell_2016,7_programs,policy_social,2_medical insurance changes
Powell_2018,2_legislations,policy_legislative,4_legalization
Pradel_2009,7_programs,policy_legislative,1_regulation of prescription drugs
Rafful_2018,2_legislations,policy_clinical,7_compulsory treatment
Raji_2017,3_regulation,policy_legislative,9090_pain clinic laws
Raji_2018,3_regulation,policy_prescription,1_drug rescheduling
Ranapurwala_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Rasubala_2015,2_legislations,policy_prescription,9090_Registry of schedule II drugs consulted before script
Rasubala_2015,3_regulation,policy_prescription,9090_Registry of schedule II drugs consulted before script
Rees_2019,2_legislations,policy_harm,9090_naloxone
Rees_2019,2_legislations,policy_legislative,5_first responders
Reifler_2012,7_programs,policy_legislative,1_regulation of prescription drugs
Reisman_2009,2_legislations,policy_legislative,1_regulation of prescription drugs
Reitan_2016,2_legislations,policy_clinical,7_compulsory treatment
Rengifo_2010,2_legislations,policy_criminal,9090_bill 123 - compulsory treatment instead of prison
Rengifo_2010,2_legislations,policy_clinical,7_compulsory treatment
Reset_2018,3_regulation,policy_prescription,3_withdraw drug
Resiak_2016,7_programs,policy_harm,1_needle exchange/availability
Resiak_2016,7_programs,policy_criminal,9090_diversion
Resiak_2016,7_programs,policy_clinical,1_availability of OAT
Resiak_2016,7_programs,policy_clinical,7_compulsory treatment
Rhodes_2015,7_programs,policy_clinical,1_availability of OAT
Rich_2015,7_programs,policy_clinical,9090_Discontinuation of methadone maintenance-treatment programme after incarceration
Riggs_2017,2_legislations,policy_social,2_medical insurance changes
Rinaldo_2013,2_legislations,policy_social,2_medical insurance changes
Ringwalt_2015,2_legislations,policy_legislative,1_regulation of prescription drugs
Ritter_2005,4_government policy,policy_clinical,9090_take-away methadone policies
Roberts_2014,2_legislations,policy_social,2_medical insurance changes
Roberts_2016,2_legislations,policy_social,2_medical insurance changes
Robinson_2010,2_legislations,policy_legislative,1_regulation of prescription drugs
Robles_2001,7_programs,policy_clinical,1_availability of OAT
Robles_2001,7_programs,policy_clinical,9090_Patient determined methadone dose
Romelsjo_2010,5_guidelines,policy_clinical,1_availability of OAT
Rosenblum_2002,1_legal,policy_criminal,1_drug courts
Rosenblum_2002,1_legal,policy_legislative,2_illicit drug policies
Rosenblum_2002,2_legislations,policy_criminal,1_drug courts
Rosenblum_2002,2_legislations,policy_legislative,2_illicit drug policies
Rossiter_2014,3_regulation,policy_prescription,2_changes in drug formulation
Rousseau_2017,1_legal,policy_criminal,2_punitive charges
Rudolph_2011,5_guidelines,policy_clinical,"9090_Discharge-on-scene policy, where Medical Emergency Care Unit (MECU) are allowed to administer naloxone in case of opioid overdose, and if patient shows a substantial and lasting improvement in vital signs, they are released on scene (not hospitalised)"
Russoniello_2012,1_legal,policy_legislative,3_decriminalization
Russoniello_2012,2_legislations,policy_legislative,3_decriminalization
Rutkow_2015,4_government policy,policy_legislative,1_regulation of prescription drugs
Sacks_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Salmon_2009,7_programs,policy_harm,3_SIS
Saloner_2016,4_government policy,policy_social,9090_Medicaid funding policies for OAT
Saloner_2017,2_legislations,policy_social,2_medical insurance changes
Saloner_2018,4_government policy,policy_social,2_medical insurance changes
Saloner_2018,4_government policy,policy_clinical,1_availability of OAT
Saloner_2018,4_government policy,policy_prescription,1_drug rescheduling
Saloner_2018,5_guidelines,policy_social,2_medical insurance changes
Saloner_2018,5_guidelines,policy_clinical,1_availability of OAT
Saloner_2018,5_guidelines,policy_prescription,1_drug rescheduling
Saloner_2018,7_programs,policy_social,2_medical insurance changes
Saloner_2018,7_programs,policy_clinical,1_availability of OAT
Saloner_2018,7_programs,policy_prescription,1_drug rescheduling
Sander_2016,3_regulation,policy_harm,1_needle exchange/availability
Sander_2016,3_regulation,policy_clinical,1_availability of OAT
Sandlilands_2008,3_regulation,policy_prescription,3_withdraw drug
Sankey_2016,4_government policy,policy_prescription,2_changes in drug formulation
Sanmartin_2019,4_government policy,policy_criminal,2_punitive charges
Santistevan_2018,7_programs,policy_clinical,9090_removal default # tablets prescribed in ED
Saulle_2017,4_government policy,policy_clinical,9090_supervised dosing policies
Saunders_2014,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Schackman_2006,2_legislations,policy_legislative,1_regulation of prescription drugs
Schaffer_2018,3_regulation,policy_prescription,2_changes in drug formulation
Schaffer_2019,3_regulation,policy_social,9090_subsidizing of controlled‐release oxycodone
Schill_2018,2_legislations,policy_legislative,5_first responders
Schultz_2016,3_regulation,policy_prescription,1_drug rescheduling
Schwartz_2013,2_legislations,policy_clinical,1_availability of OAT
Seago_2016,3_regulation,policy_prescription,1_drug rescheduling
Sears_2009,7_programs,policy_clinical,1_availability of OAT
Sears_2019,5_guidelines,policy_clinical,4_opioid prescribing standards
Sellars_2013,3_regulation,policy_prescription,2_changes in drug formulation
Sessler_2014,3_regulation,policy_prescription,2_changes in drug formulation
Severtson_2013,3_regulation,policy_prescription,2_changes in drug formulation
Severtson_2016,3_regulation,policy_prescription,2_changes in drug formulation
Sevigny_2013,7_programs,policy_criminal,1_drug courts
Shaffer_2011,7_programs,policy_criminal,1_drug courts
Shah_2019,2_legislations,policy_legislative,4_legalization
Sham_2011,2_legislations,policy_criminal,1_drug courts
Sham_2011,2_legislations,policy_criminal,9090_CAP Laws for parents not locking away prescriptions
Sham_2011,2_legislations,policy_legislative,1_regulation of prescription drugs
Sharareh_2019,2_legislations,policy_law_enforce,1_policing tactics
Sharareh_2019,2_legislations,policy_harm,3_SIS
Sharareh_2019,2_legislations,policy_criminal,9090_diversion
Sharareh_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Sharareh_2019,2_legislations,policy_clinical,1_availability of OAT
Sharareh_2019,2_legislations,policy_clinical,4_opioid prescribing standards
Sharareh_2019,2_legislations,policy_prescription,2_changes in drug formulation
Sharareh_2019,2_legislations,policy_prescription,9090_HAT
Sharareh_2019,3_regulation,policy_law_enforce,1_policing tactics
Sharareh_2019,3_regulation,policy_harm,3_SIS
Sharareh_2019,3_regulation,policy_criminal,9090_diversion
Sharareh_2019,3_regulation,policy_legislative,1_regulation of prescription drugs
Sharareh_2019,3_regulation,policy_clinical,1_availability of OAT
Sharareh_2019,3_regulation,policy_clinical,4_opioid prescribing standards
Sharareh_2019,3_regulation,policy_prescription,2_changes in drug formulation
Sharareh_2019,3_regulation,policy_prescription,9090_HAT
Sharareh_2019,7_programs,policy_law_enforce,1_policing tactics
Sharareh_2019,7_programs,policy_harm,3_SIS
Sharareh_2019,7_programs,policy_criminal,9090_diversion
Sharareh_2019,7_programs,policy_legislative,1_regulation of prescription drugs
Sharareh_2019,7_programs,policy_clinical,1_availability of OAT
Sharareh_2019,7_programs,policy_clinical,4_opioid prescribing standards
Sharareh_2019,7_programs,policy_prescription,2_changes in drug formulation
Sharareh_2019,7_programs,policy_prescription,9090_HAT
Sharma_2017,2_legislations,policy_criminal,2_punitive charges
Sharma_2017,2_legislations,policy_clinical,7_compulsory treatment
Sharp_2018,2_legislations,policy_clinical,1_availability of OAT
Shearer_2007,7_programs,policy_clinical,1_availability of OAT
Shepherd_2014,2_legislations,policy_legislative,1_regulation of prescription drugs
Shi_2017,2_legislations,policy_legislative,4_legalization
Shi_2019,2_legislations,policy_legislative,4_legalization
Shi_2019,3_regulation,policy_legislative,4_legalization
Shi_2019,7_programs,policy_legislative,4_legalization
Shover_2019,2_legislations,policy_legislative,4_legalization
Showalter_2018,4_government policy,policy_harm,1_needle exchange/availability
Shumway_2018,3_regulation,policy_prescription,1_drug rescheduling
Shumway_2019,8_strategies,policy_legislative,2_illicit drug policies
Siddiqui_2015,2_legislations,policy_harm,1_needle exchange/availability
Simojoki_2008,3_regulation,policy_clinical,9090_forced transfer from Subutex to Suboxone after it was made available with special licence
Simoni-Wastila_2012,2_legislations,policy_legislative,1_regulation of prescription drugs
Skinner_2016,7_programs,policy_social,2_medical insurance changes
SKodbo_2007,7_programs,policy_criminal,9090_Diversion
Skretting_2010,3_regulation,policy_clinical,1_availability of OAT
Skretting_2010,5_guidelines,policy_clinical,1_availability of OAT
Smith_2012,4_government policy,policy_harm,1_needle exchange/availability
Smith_2012,4_government policy,policy_clinical,1_availability of OAT
Smith_2015,1_legal,policy_criminal,9090_Safe harbour act
Smith_2015,2_legislations,policy_criminal,9090_Safe harbour act
Smithson_2005,8_strategies,policy_law_enforce,1_policing tactics
Smyth_2015,2_legislations,policy_criminal,2_punitive charges
Smyth_2019,2_legislations,policy_criminal,2_punitive charges
Snider_2019,2_legislations,policy_social,2_medical insurance changes
Socias_2017,3_regulation,policy_prescription,2_changes in drug formulation
Socias_2017,3_regulation,policy_prescription,9090_restrictions in pharmacy delivery services
Sohn_2019,2_legislations,policy_harm,9090_mandated co-prescriptions of naloxone
Sohn_2019,4_government policy,policy_harm,9090_mandated co-prescriptions of naloxone
Soni_2018,7_programs,policy_prescription,9090_Effect of increase prescription prices on opioid consumption
Soper_2018,7_programs,policy_prescription,2_changes in drug formulation
Sorensen_2009,7_programs,policy_clinical,1_availability of OAT
Spooner_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
Spooner_2016,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
Spooner_2016,5_guidelines,policy_legislative,1_regulation of prescription drugs
Spooner_2016,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Srubar_2015,8_strategies,policy_international,1_international drug treaties
Srubar_2015,8_strategies,policy_international,9090_International cooperation
Srubar_2015,8_strategies,policy_international,9090_2_Extradition
Srubar_2015,8_strategies,policy_international,9090_3_Mutual legal assistance
Stanos_2012,8_strategies,policy_clinical,9090_ER/LA Risk Evaluation and Mitigation Strategy
Stark_2002,1_legal,policy_legislative,1_regulation of prescription drugs
Stark_2002,1_legal,policy_clinical,5_opioid prescribing standards - provider - doctor
Stark_2002,1_legal,policy_clinical,9090_pain management
Stark_2002,2_legislations,policy_legislative,1_regulation of prescription drugs
Stark_2002,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
Stark_2002,2_legislations,policy_clinical,9090_pain management
Stark_2002,5_guidelines,policy_legislative,1_regulation of prescription drugs
Stark_2002,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Stark_2002,5_guidelines,policy_clinical,9090_pain management
Stark_2002,6_standards,policy_legislative,1_regulation of prescription drugs
Stark_2002,6_standards,policy_clinical,5_opioid prescribing standards - provider - doctor
Stark_2002,6_standards,policy_clinical,9090_pain management
Steckler_2019,3_regulation,policy_prescription,1_drug rescheduling
Steffen_2016,1_legal,policy_criminal,1_drug courts
Steffen_2016,1_legal,policy_clinical,7_compulsory treatment
Steffen_2016,2_legislations,policy_criminal,1_drug courts
Steffen_2016,2_legislations,policy_clinical,7_compulsory treatment
Stein_2014,2_legislations,policy_clinical,2_availability of OAT - provider - doctors
Stein_2015,4_government policy,policy_clinical,2_availability of OAT - provider - doctors
Stein_2015,4_government policy,policy_clinical,5_opioid prescribing standards - provider - doctor
Stein_2015,5_guidelines,policy_clinical,2_availability of OAT - provider - doctors
Stein_2015,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Stemen_2012,2_legislations,policy_criminal,9090_bill 123 - compulsory treatment instead of prison
Stemen_2012,2_legislations,policy_clinical,7_compulsory treatment
Stevenson_2002,2_legislations,policy_social,1_welfare expansion/reform
Stevenson_2002,2_legislations,policy_social,2_medical insurance changes
Stevenson_2002,7_programs,policy_social,1_welfare expansion/reform
Stevenson_2002,7_programs,policy_social,2_medical insurance changes
Steverson_2009,2_legislations,policy_harm,9090_Treatment for pregnant women/mothers with addictions
Steverson_2009,2_legislations,policy_legislative,9090_State legislation of treatment for pregnant or parenting women that use substances
Steverson_2009,2_legislations,policy_social,2_medical insurance changes
Steverson_2009,7_programs,policy_harm,9090_Treatment for pregnant women/mothers with addictions
Steverson_2009,7_programs,policy_legislative,9090_State legislation of treatment for pregnant or parenting women that use substances
Steverson_2009,7_programs,policy_social,2_medical insurance changes
Stoever_2002,7_programs,policy_harm,1_needle exchange/availability
Stoever_2002,7_programs,policy_clinical,1_availability of OAT
Stover_2006,4_government policy,policy_clinical,1_availability of OAT
Strickler_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Strike_2005,2_legislations,policy_clinical,1_availability of OAT
Strike_2005,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
Strike_2005,4_government policy,policy_clinical,1_availability of OAT
Strike_2005,4_government policy,policy_clinical,5_opioid prescribing standards - provider - doctor
Strike_2005,5_guidelines,policy_clinical,1_availability of OAT
Strike_2005,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Stucke_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Suffoletto_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Sullivan_2016,3_regulation,policy_prescription,1_drug rescheduling
Sun_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Sun_2017,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
Sun_2017,2_legislations,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Sun_2017,2_legislations,policy_clinical,9090_hospital 'best practices' including introduction of EDIE system
Sun_2017,5_guidelines,policy_legislative,1_regulation of prescription drugs
Sun_2017,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Sun_2017,5_guidelines,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Sun_2017,5_guidelines,policy_clinical,9090_hospital 'best practices' including introduction of EDIE system
Sun_2017,6_standards,policy_legislative,1_regulation of prescription drugs
Sun_2017,6_standards,policy_clinical,5_opioid prescribing standards - provider - doctor
Sun_2017,6_standards,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Sun_2017,6_standards,policy_clinical,9090_hospital 'best practices' including introduction of EDIE system
Sun_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Sung_2011,1_legal,policy_criminal,1_drug courts
Sung_2018,2_legislations,policy_legislative,3_decriminalization
Surratt_2014,2_legislations,policy_legislative,9090_pain clinic laws
Surratt_2014,3_regulation,policy_legislative,9090_pain clinic laws
Swartz_2019,2_legislations,policy_social,2_medical insurance changes
Tadrous_2019,7_programs,policy_clinical,9090_patch for patch program
Tami_2014,4_government policy,policy_clinical,1_availability of OAT
Tan_2018,3_regulation,policy_prescription,1_drug rescheduling
Tempalski_2008,4_government policy,policy_harm,1_needle exchange/availability
Tempalski_2008,7_programs,policy_harm,1_needle exchange/availability
Tenney_2018,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Tesoriero_2009,7_programs,policy_harm,1_needle exchange/availability
The Network for Public Health Law_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
The Network for Public Health Law_2018,2_legislations,policy_legislative,5_first responders
Thomas_2013,3_regulation,policy_legislative,1_regulation of prescription drugs
Thongkhamcharoen_2012,2_legislations,policy_legislative,1_regulation of prescription drugs
Thongkhamcharoen_2012,2_legislations,policy_clinical,4_opioid prescribing standards
Thongkhamcharoen_2012,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
Thongkhamcharoen_2012,2_legislations,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Thongkhamcharoen_2012,5_guidelines,policy_legislative,1_regulation of prescription drugs
Thongkhamcharoen_2012,5_guidelines,policy_clinical,4_opioid prescribing standards
Thongkhamcharoen_2012,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Thongkhamcharoen_2012,5_guidelines,policy_clinical,6_opioid prescribing standards - provider - pharmacist
Townsend_2019,7_programs,policy_harm,9090_naloxone distribution program
Tran_2012,7_programs,policy_harm,9090_Methadone Maintenance Treatment
Tran_2016,7_programs,policy_clinical,1_availability of OAT
Tran_2017,2_legislations,policy_prescription,1_drug rescheduling
Tran_2017,3_regulation,policy_prescription,1_drug rescheduling
Turner_2013,7_programs,policy_clinical,9090_opioid risk reduction initiative to increase urine testing
Twillman_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
Twillman_2016,2_legislations,policy_clinical,4_opioid prescribing standards
Twillman_2016,3_regulation,policy_legislative,1_regulation of prescription drugs
Twillman_2016,3_regulation,policy_clinical,4_opioid prescribing standards
Twillman_2016,4_government policy,policy_legislative,1_regulation of prescription drugs
Twillman_2016,4_government policy,policy_clinical,4_opioid prescribing standards
Twillman_2016,5_guidelines,policy_legislative,1_regulation of prescription drugs
Twillman_2016,5_guidelines,policy_clinical,4_opioid prescribing standards
Tyndall_2002,4_government policy,policy_harm,1_needle exchange/availability
Unger_2014,2_legislations,policy_legislative,1_regulation of prescription drugs
van Ameijden_2001,4_government policy,policy_harm,1_needle exchange/availability
van Ameijden_2001,7_programs,policy_harm,1_needle exchange/availability
van Ganse_2018,3_regulation,policy_prescription,3_withdraw drug
vanBurskirk_2017,8_strategies,policy_law_enforce,1_policing tactics
vandewalker_2008,1_legal,policy_criminal,2_punitive charges
vandewalker_2008,1_legal,policy_criminal,9090_Termination of parental rights for pregnant women who use substances.
vandewalker_2008,2_legislations,policy_criminal,2_punitive charges
vandewalker_2008,2_legislations,policy_criminal,9090_Termination of parental rights for pregnant women who use substances.
Varisco_2017,2_legislations,policy_prescription,1_drug rescheduling
von Korff_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
von Korff_2016,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
von Korff_2016,5_guidelines,policy_legislative,1_regulation of prescription drugs
von Korff_2016,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
von Korff_2017,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
von Korff_2019,2_legislations,policy_clinical,4_opioid prescribing standards
von Korff_2019,5_guidelines,policy_clinical,4_opioid prescribing standards
vonaarburg_2004,3_regulation,policy_law_enforce,1_policing tactics
Vongchak_2005,2_legislations,policy_legislative,2_illicit drug policies
Vosburg_2017,3_regulation,policy_prescription,2_changes in drug formulation
Vranken_2014,2_legislations,policy_legislative,1_regulation of prescription drugs
Vranken_2016,2_legislations,policy_legislative,1_regulation of prescription drugs
Vranken_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Vuong_2018,4_government policy,policy_clinical,1_availability of OAT
Vuong_2018,4_government policy,policy_clinical,7_compulsory treatment
Vuong_2018,7_programs,policy_clinical,1_availability of OAT
Vuong_2018,7_programs,policy_clinical,7_compulsory treatment
Vyas_2018,2_legislations,policy_legislative,4_legalization
Waal_2014,2_legislations,policy_law_enforce,1_policing tactics
Waal_2014,2_legislations,policy_harm,3_SIS
Waal_2014,2_legislations,policy_criminal,2_punitive charges
Waal_2014,2_legislations,policy_legislative,2_illicit drug policies
Waal_2014,2_legislations,policy_legislative,3_decriminalization
Waal_2014,2_legislations,policy_social,1_welfare expansion/reform
Waal_2014,2_legislations,policy_clinical,7_compulsory treatment
Waal_2014,3_regulation,policy_law_enforce,1_policing tactics
Waal_2014,3_regulation,policy_harm,3_SIS
Waal_2014,3_regulation,policy_criminal,2_punitive charges
Waal_2014,3_regulation,policy_legislative,2_illicit drug policies
Waal_2014,3_regulation,policy_legislative,3_decriminalization
Waal_2014,3_regulation,policy_social,1_welfare expansion/reform
Waal_2014,3_regulation,policy_clinical,7_compulsory treatment
Waal_2014,7_programs,policy_law_enforce,1_policing tactics
Waal_2014,7_programs,policy_harm,3_SIS
Waal_2014,7_programs,policy_criminal,2_punitive charges
Waal_2014,7_programs,policy_legislative,2_illicit drug policies
Waal_2014,7_programs,policy_legislative,3_decriminalization
Waal_2014,7_programs,policy_social,1_welfare expansion/reform
Waal_2014,7_programs,policy_clinical,7_compulsory treatment
Wade_2017,3_regulation,policy_social,2_medical insurance changes
Wakeland_2013,7_programs,policy_clinical,9090_educational interventions
Wakeland_2015,2_legislations,policy_prescription,2_changes in drug formulation
Waldrop_2017,2_legislations,policy_criminal,1_drug courts
Waldrop_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Waldrop_2017,5_guidelines,policy_criminal,1_drug courts
Waldrop_2017,5_guidelines,policy_legislative,1_regulation of prescription drugs
Waldrop_2017,7_programs,policy_criminal,1_drug courts
Waldrop_2017,7_programs,policy_legislative,1_regulation of prescription drugs
Walley_2013,7_programs,policy_harm,9090_overdose education and nasal naloxone distribution (OEND) program
Wan_2016,8_strategies,policy_law_enforce,1_policing tactics
Wang_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Wang_2019,2_legislations,policy_clinical,9090_Health information technology
Wang_2019,7_programs,policy_legislative,1_regulation of prescription drugs
Wang_2019,7_programs,policy_clinical,9090_Health information technology
Warren_2018,2_legislations,policy_criminal,1_drug courts
Warren_2018,2_legislations,policy_criminal,9090_early diversion
Web_2016,2_legislations,policy_clinical,7_compulsory treatment
Weber_2010,2_legislations,policy_legislative,1_regulation of prescription drugs
Weber_2010,2_legislations,policy_clinical,2_availability of OAT - provider - doctors
Weber_2010,2_legislations,policy_clinical,5_opioid prescribing standards - provider - doctor
Weber_2010,3_regulation,policy_legislative,1_regulation of prescription drugs
Weber_2010,3_regulation,policy_clinical,2_availability of OAT - provider - doctors
Weber_2010,3_regulation,policy_clinical,5_opioid prescribing standards - provider - doctor
Weber_2010,5_guidelines,policy_legislative,1_regulation of prescription drugs
Weber_2010,5_guidelines,policy_clinical,2_availability of OAT - provider - doctors
Weber_2010,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Wegman_2017,7_programs,policy_clinical,1_availability of OAT
Wegman_2017,7_programs,policy_clinical,7_compulsory treatment
Weimer_2016,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Weiner_2017,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Weisberg_2016,1_legal,policy_criminal,2_punitive charges
Weisberg_2016,1_legal,policy_legislative,2_illicit drug policies
Weisberg_2016,1_legal,policy_clinical,1_availability of OAT
Weisberg_2016,1_legal,policy_clinical,7_compulsory treatment
Weisberg_2016,2_legislations,policy_criminal,2_punitive charges
Weisberg_2016,2_legislations,policy_legislative,2_illicit drug policies
Weisberg_2016,2_legislations,policy_clinical,1_availability of OAT
Weisberg_2016,2_legislations,policy_clinical,7_compulsory treatment
Wen_2013,2_legislations,policy_social,2_medical insurance changes
Wen_2015,2_legislations,policy_legislative,4_legalization
Wen_2017,2_legislations,policy_social,2_medical insurance changes
Wen_2017a,4_government policy,policy_legislative,1_regulation of prescription drugs
Wen_2018,2_legislations,policy_legislative,4_legalization
Wen_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Werb_2013,2_legislations,policy_legislative,9090_Prescription of heroine-assisted treatment (HAT)
Westanmo_2015,7_programs,policy_clinical,5_opioid prescribing standards - provider - doctor
Wettstein_2019,2_legislations,policy_social,2_medical insurance changes
Whitelaw_2017,2_legislations,policy_legislative,3_decriminalization
Whitmore_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Wickramatilake_2017,2_legislations,policy_theme,9090_educational campaigns targeting public and doctors
Wickramatilake_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Wickramatilake_2017,2_legislations,policy_legislative,5_first responders
Wickramatilake_2017,2_legislations,policy_clinical,1_availability of OAT
Wickramatilake_2017,2_legislations,policy_clinical,4_opioid prescribing standards
Wickramatilake_2017,7_programs,policy_theme,9090_educational campaigns targeting public and doctors
Wickramatilake_2017,7_programs,policy_legislative,1_regulation of prescription drugs
Wickramatilake_2017,7_programs,policy_legislative,5_first responders
Wickramatilake_2017,7_programs,policy_clinical,1_availability of OAT
Wickramatilake_2017,7_programs,policy_clinical,4_opioid prescribing standards
Williams_2014,2_legislations,policy_clinical,7_compulsory treatment
Wilson_2006,7_programs,policy_criminal,1_drug courts
Wilson_2018,7_programs,policy_criminal,9090_Diversion
Wilson_2019,2_legislations,policy_legislative,1_regulation of prescription drugs
Winstanley_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Wittouck_2013,7_programs,policy_criminal,1_drug courts
Wong_2019,2_legislations,policy_legislative,4_legalization
Wood_2003,8_strategies,policy_law_enforce,1_policing tactics
Wood_2004,8_strategies,policy_law_enforce,1_policing tactics
Wood_2004_2,7_programs,policy_harm,3_SIS
Wood_2006,7_programs,policy_harm,3_SIS
Woodworth_2013,2_legislations,policy_legislative,1_regulation of prescription drugs
Worrall_2009,2_legislations,policy_criminal,1_drug courts
Wright_2017,2_legislations,policy_legislative,1_regulation of prescription drugs
Xu_2018,2_legislations,policy_harm,9090_naloxone access laws
Xu_2018,4_government policy,policy_harm,9090_naloxone access laws
Yarbrough_2015,2_legislations,policy_legislative,1_regulation of prescription drugs
Yarbrough_2018,2_legislations,policy_legislative,1_regulation of prescription drugs
Yenikomshian_2019,3_regulation,policy_prescription,2_changes in drug formulation
Young_2017,7_programs,policy_clinical,9090_Inform physicians if patient 4+ providers through letter
Zanis_2003,7_programs,policy_criminal,9090_Early prison release & entry into substance abuse and treatment facility
Zarkin_2005,7_programs,policy_criminal,9090_diversion
Zarkin_2011,7_programs,policy_clinical,1_availability of OAT
Zarkin_2012,7_programs,policy_criminal,9090_Diversion
Zhu_2019,2_legislations,policy_social,2_medical insurance changes
Zolin_2019,5_guidelines,policy_clinical,5_opioid prescribing standards - provider - doctor
Zurhold_2003,2_legislations,policy_harm,3_SIS
